Category: COVID-19 Vaccine

  • MIL-OSI NGOs: People fleeing violence in North Darfur need shelter, water, and food story May 06, 2025

    Source: Doctors Without Borders –

    In the weeks since the Rapid Support Forces (RSF) conducted a large-scale ground offensive on Sudan’s Zamzam camp, where nearly 500,000 people were taking shelter, tens of thousands of people are fleeing to areas including the town of Tawila, in North Darfur, while intense fighting reportedly continues in the state capital, El Fasher. 

    People are arriving in Tawila from Zamzam in extreme need; famine was declared in the camp in August 2024, and many people have been seriously injured in the attack. Doctors Without Borders/Médecins Sans Frontières (MSF) is providing medical care in dedicated health posts in Tawila, as well as distributing water and donating dry food, but the needs of the arriving people are overwhelming emergency and nutritional services at the local hospital that MSF supports. People speak of fleeing horrific violence.

    Why are people fleeing Zamzam and going to Tawila?

    • On April 11, the Rapid Support Forces (RSF), one of the parties in the war in Sudan, launched a massive ground offensive on Zamzam camp, North Darfur, which is home to at least 500,000 displaced people. Hundreds of people are estimated to have been killed.
    • MSF teams in Tawila, about 35 miles away, witnessed the arrival of thousands of displaced families, who told us that fighters  were going door-to-door, shooting people hiding in their homes, and burning large parts of the camp. 
    • The two health posts MSF set up at the main arrival sites in Tawila have been overwhelmed for two weeks in a row, providing up to 850 medical consultations per day, with patients suffering advanced states of dehydration and exhaustion. People have also arrived with gunshots and shrapnel injuries. MSF has set up a mass casualty plan, and in three weeks, our teams treated 779 patients with gunshot and shrapnel wounds, including 138 children under 15. Of these, 187 were severe cases (including 24 children). 
    • Tens of thousands of people have now set up makeshift shelters in the surroundings of Tawila, and are trying to survive in extremely dire conditions.

    Dr. Mohamed Abubaker examines a patient in the pediatrics department in Tawila. | Sudan 2025 © Thibault Fendler/MSF

    The RSF came with their machine guns and drones,” says Mariam* who reached Tawila three days after the attack on Zamzam took place. “They attacked and killed [people]—including children. They burned our house with everything we had inside. They raped the women. They killed, they looted. Even before the attack, people had died of thirst and of starvation because of the siege that had been imposed on Zamzam for the past year. … They entered the house of one of my sisters, dragged her out, and killed her. My uncle’s son, my aunt’s son, and many people were killed. They slaughtered us like animals.”

    Mariam arrived in Tawila with 20 family members, including her mother, her sisters and their own children. They now spend their days crammed into a makeshift shelter they built with branches and a piece of fabric, sharing the little shade it provides.

    Makeshift shelters have filled what was an empty grass field in Tawila, as thousands of families flee the massive offensive on Zamzam camp. | Sudan 2025 © Thibault Fendler/MSF

    Newly displaced people are living in fields

    Since April 12, when the people first began reaching Tawila from Zamzam, the areas surrounding the town have been completely transformed, with tens of thousands of people now estimated to be living in makeshift shelters in fields that were totally uninhabited just a few weeks ago.

    “For four days now, we have been staying here as you see us, with nothing: no walls, no roof,” says Ibrahim, who fled Zamzam on foot with 11 of his family members. He carried one of his children on his shoulders and another on his back for five days. It’s the fourth time in 10 years he has been displaced in similar circumstances. He describes how soldiers entered people’s homes, forced them outside, and opened fire. Three of his brothers were killed in this manner. On his way to Tawila, he was robbed and witnessed people being beaten so harshly that they could no longer move.

    “We don’t see any future anymore”

    “I’ve been displaced four times over the past 10 years. We arrived in Tawila on April 16. We have been living here since then, under this tree, all 11 of us.

    On Friday, April 11, it started with shelling directly on the camp. Shells were falling where people were gathering. Then they attacked on the ground. We heard gunfire everywhere. Many people got killed, including three of my brothers. Soldiers entered their houses, brought them outside, and opened fire.

    When we managed to leave Zamzam, we left on foot. We had no vehicles, no donkey, no cart, nothing. I had one of my children on my shoulders, another one on my back. My older son and daughter were carrying their younger siblings the same way. Everyone around us was doing the same.

    We were stopped at the exit of the camp by armed men. They searched everyone, even the smallest children. There were looking for anything that had value. Some of us were beaten so harshly, they were not able to move anymore.

    The first night, we took shelter a few miles from there, in the valley of Golo. But there as well, they came for us, to steal from us. We had nothing left, but all those who did, got looted and beaten, once again.

    For four days now, we have been staying here with nothing—no walls, no roof. Under this tree, it is so crowded. We’re lacking water, shelter, and there is nothing to eat. Everyone is hungry. We’re getting most of our food from community kitchens. Sometimes, we manage to get some rice when they distribute meals, but if we don’t, we must wait until the next day to eat something. For the water, we go to the well, which is a bit further away, with our jerrycans. But there are many people, and we have to wait hours to be able to drink. 

    We have nothing left—no money, nothing that could help us leave. We just stay here, hoping we will get enough food to survive on the next day. We don’t see any future anymore.”

    -Ibrahim*

    Needs far outweigh available assistance

    A handful of organizations are present in Tawila, but the number of people in need of assistance far exceeds the capacity to respond. MSF teams have set up two health posts at the main arrival sites to provide newcomers with water and immediate nutritional and medical support, and are referring critical patients to the local hospital that MSF has been supporting since October 2024.

    “Every single person they saw, they shot at”

    “In my life, I have been displaced many times by the violence, from Sarafaya to Mouqrin in 2014, then to Shagra last year, and to Zamzam earlier this year, to finally arrive here, in Tawila. It was on Monday, April 14.

    It was already a similar attack that made us flee from Shagra to Zamzam. In 2024, attackers came on camels and motorcycles and stole everything from us: our horses, our donkeys, our camels, even the tobacco we had just harvested. 

    When we got to Zamzam, the camp was already under siege. Everything was blocked, no supplies entering anymore. Everything became so expensive: food was not affordable anymore. Then the attack on Zamzam happened. It has started with a lot of shelling and then shooting. They came walking, directly inside the camp. Every single person they saw, they shot at them, not matter if it was a child, a woman, or an old person. 

    At the exit of the camp, they were waiting for us. They searched the women, they took anything they thought had value: our money, our cell phones, even our clothes. And on the road to Tawila, it happened again. What little we had left was looted on the way, including our blankets. 

    I arrived to Tawila with my children. I came walking, carrying my youngest children on our donkey. The little water we had was finished. I saw two bodies on the way, with my own eyes. Dead from thirst. 

    Living conditions here are terrible. My elder children go to the market, they buy big boxes of biscuits they then resell by unit. With that very little money, we manage to survive. For water, we can go to a water tank which is a bit further away, but sometimes it’s empty. We managed to buy two jerrycans on the market, but here as well, they were really expensive.

    My children are coughing a lot. We have been to MSF’s health post; they gave us medications, but their condition is not improving. Nights are so cold; we are sleeping on the floor and only have two blankets for the 11 of us.

    As long as we remain safe here, we will stay. And if not… well, we will leave. Once again.”

    Hamida* 

    Tiphaine Salmon, MSF head nurse, was working in the hospital on the day the mass influx of severe cases began on April 12. “The emergency room was overwhelmed,” she says. “Over the first few days, the number of patients in the hospital almost doubled. At one point, we had four patients in a bed because we did not have enough space. A lot of people had gunshot wounds and blast injuries—we’ve treated 779 people over the past three weeks, including 138 children. Of the 779 patients, 187 were severe cases. The youngest I saw was a 7-month-old baby with a bullet wound that went under his chin and into his shoulder. We also received patients as young as 1 day old suffering from dehydration. Many children arrived without their parents—and many parents were searching desperately for their children.”

    At the same time, our teams in the hospital witnessed an explosion of admissions in our intensive therapeutical feeding center, which treats children under 5 years old suffering from severe acute malnutrition. In the week following the influx, admissions increased almost tenfold, from an average of 6 or 7 per week to more than 60. They were mostly children from Zamzam.

    MSF nurse Hitham checks a patient at an MSF health post in Tawila Umda, where hundreds of people suffering from exhaustion and dehydration have arrived over the past few days. | Sudan 2025 © Thibault Fendler/MSF

    Disease and displacement make a deadly combination

    A suspected measles outbreak began in Tawila in March, worsening an already catastrophic situation. MSF has treated more than 900 suspected measles cases since early February, with more than 300 patients in such severe condition that they required hospitalization. This situation led our teams to launch a large-scale vaccination campaign in the city in the first week of April, reaching 18,000 children under 5 years old.

    Only one week after the massive influx of people from Zamzam began, our teams saw several suspected cases among children who had just arrived from the camp, meaning that measles had already begun to spread in displacement sites.

    In such sites with a high population density and low hygiene conditions, malnutrition and measles can be an especially deadly combination, with disastrous consequences for young children.

    “They just slaughtered us like animals” 

    “Our household is composed of 20 people, including my 12 children, my mother, my sisters and their own children. We arrived from Zamzam five days ago. We were living there since 2014.

    The RSF came with their machine guns and drones. They attacked and killed, including children. They burned our house with everything we had inside. They raped the women. They killed, they looted. But even before that, people died of thirst and of starvation, because of the siege they imposed on Zamzam for the past year. Everything was so expensive and so unaffordable in the end.

    I’ve seen a full group of children being killed during the attack by a shelling. I’ve seen it with my own eyes as we were fleeing.

    Nobody will ever go there and bury them now.

    They entered the house of one of my sisters, dragged her out, and killed her. My uncle’s son, my aunt’s son, and many people were killed. They slaughtered us like animals. 

    On our way to Shagra, at a checkpoint, I asked them why they were killing us like this. They didn’t answer. They raped several girls there. They beat the people, and loot them once again, whatever they had. We had a bit of water left, but they took the bottle and emptied it on the ground, in front of us. They also took our luggage, threw everything on the ground, and chose what they wanted to keep. I only had about 1,500 Sudanese pounds on me [about $2.25], even that they took from me. 

    On the way, there were six checkpoints like this one. At every single checkpoint, they emptied our luggage, searched, and kept what had value. Then they ordered us to pick up the rest and leave immediately. 

    Here, in Tawila, there is no food. Some people in Tawila shared a bit of millet flour with us, from which we make porridge. This is how we have survived so far: begging. We have one blanket for all of us.

    We don’t have any other place to go, and even if we did, we wouldn’t have the money to do so. So, we’re just staying here, hoping to receive a bit of help. We need a better place to stay than this shelter we built with our hands.”

    Mariam*

    Immediate scale-up of aid is imperative

    MSF is continuing to scale up its intervention in Tawila. As well as carrying out hundreds of medical consultations per day, our organization has donated food to local community kitchens, enabling them to prepare and distribute more than 16,000 meals per day. We have also been providing 100,000 liters of clean water daily, and we have additional plans to construct 300 latrines.

    But the needs of people in Tawila are immense and far outstrip our capacity to respond. Although other actors have also mobilized, and a first mass food distribution has taken place, the humanitarian response still needs to be urgently and rapidly scaled up. We urge UN agencies to substantially increase their presence on the ground so they can coordinate a response with the magnitude to meet the ever-growing needs.

    *Names have been changed for privacy. 

    MIL OSI NGO

  • MIL-OSI Europe: Written question – Political pressure put on EMA over vaccine testing – E-001696/2025

    Source: European Parliament

    Question for written answer  E-001696/2025
    to the Commission
    Rule 144
    Gerald Hauser (PfE)

    The Commission is reported to have deliberately quashed important COVID-19 vaccine safety audits in 2020. The European Medicines Agency (EMA) waived mandatory inspections of test centres, saying it was because of the risk of infection and political pressure. EMA Director Emer Cooke decided to cancel missions to carry out inspections, in particular to AstraZeneca’s test sites in Brazil, for example. The decision, however, was not officially documented. Later it came out that the vaccines had many serious side effects, such as brain thrombosis. Reports of adverse reactions for the BioNTech/Pfizer vaccines were also ignored. Critics complain that the EMA relied to a large extent on manufacturer’s claims when granting authorisation. The agency has to date defended its actions.[1]

    • 1.Why was political pressure put on the EMA to suspend mandatory safety testing when approving vaccines?
    • 2.Who put political pressure on the EMA to suspend suspend mandatory safety testing when approving vaccines, and when?
    • 3.What consequences will ensue following these revelations?

    Submitted: 28.4.2025

    • [1] https://apollo-news.net/eu-kommission-unterdrckte-bewusst-sicherheitsprfungen-von-covid-impfstoffen/
    Last updated: 7 May 2025

    MIL OSI Europe News

  • MIL-OSI: Oportun Announces Continued Board Evolution

    Source: GlobeNewswire (MIL-OSI)

    SAN CARLOS, Calif., May 07, 2025 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven financial services company, today announced that its Board of Directors will nominate Carlos Minetti and Raul Vazquez for election at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”). Scott Parker and R. Neil Williams will not stand for reelection at the Annual Meeting, and the Board will be reduced from ten to eight members at that time. If the Board’s recommended candidates are elected, three of the Board’s seven independent directors will have joined the Board within eighteen months of the Annual Meeting. Following the conclusion of Mr. Williams’ tenure on the Board, the Board will select a new Lead Independent Director.

    “The Board has thoughtfully repositioned Oportun for continued success. As part of that process, we took a comprehensive look at how to maintain the Board’s strength and independence, as well as its diversity of experience and expertise,” said Mr. Williams. “After benchmarking against industry peers and corporate governance best practices, and considering the perspectives of our shareholders, we recognized that a smaller Board would be both more conventional and efficient. I have full confidence the Board will continue to provide effective guidance and hold management accountable as the Company executes its strategic initiatives.”

    “On behalf of the Board, I’d like to thank Scott and Neil for their service and contributions to the Company. We wish them all the best in their future endeavors,” said Ginny Lee, Chair of the Nominating, Governance and Social Responsibility Committee. “Looking ahead, we remain focused on vigorous and independent oversight of the Company’s strategy and execution, with a goal of driving improved operating performance and delivering enhanced shareholder value.”

    About Oportun

    Oportun (Nasdaq: OPRT) is a mission-driven financial services company that puts its members’ financial goals within reach. With intelligent borrowing, savings, and budgeting capabilities, Oportun empowers members with the confidence to build a better financial future. Since inception, Oportun has provided more than $19.7 billion in responsible and affordable credit, saved its members more than $2.4 billion in interest and fees, and helped its members save an average of more than $1,800 annually. For more information, visit Oportun.com.

    Forward-Looking Statements

    This press release contains forward-looking statements. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this press release, including statements as to our future performance and financial position, are forward-looking statements. These statements can be generally identified by terms such as “expect,” “plan,” “goal,” “target,” “anticipate,” “assume,” “predict,” “project,” “outlook,” “continue,” “due,” “may,” “believe,” “seek,” or “estimate” and similar expressions or the negative versions of these words or comparable words, as well as future or conditional verbs such as “will,” “should,” “would,” “likely” and “could.” These statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events, financial trends and risks and uncertainties that we believe may affect our business, financial condition and results of operations. These risks and uncertainties include those risks described in our filings with the Securities and Exchange Commission, including our most recent annual report on Form 10-K. These forward-looking statements speak only as of the date on which they are made and, except to the extent required by federal securities laws, we disclaim any obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. In light of these risks and uncertainties, there is no assurance that the events or results suggested by the forward-looking statements will in fact occur, and you should not place undue reliance on these forward-looking statements.

    Additional Information and Where to Find It

    Oportun Financial Corporation (“Oportun”), its directors and certain executive officers are participants in the solicitation of proxies from stockholders in connection with Oportun’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”). Oportun plans to file a proxy statement (the “2025 Proxy Statement”) with the Securities and Exchange Commission (the “SEC”) in connection with the solicitation of proxies for the Annual Meeting.

    Jo Ann Barefoot, Mohit Daswani, Ginny Lee, Carlos Minetti, Louis Miramontes, Scott Parker, Sandra A. Smith, Richard Tambor, Raul Vazquez and R. Neil Williams, all of whom are members of Oportun’s board of directors, are participants in Oportun’s solicitation. Additional information regarding such participants, including their direct or indirect interests, by security holdings or otherwise, will be included in the 2025 Proxy Statement and other relevant documents to be filed with the SEC in connection with the Annual Meeting. Information relating to the foregoing can also be found in Oportun’s definitive proxy statement for its 2024 Annual Meeting of Stockholders (the “2024 Proxy Statement”), which was filed with the SEC on May 13, 2024, and is available here. Particular attention is directed to the sections of the 2024 Proxy Statement captioned “Directors, Executive Officers and Corporate Governance,” “Non-Employee Director Compensation,” “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters,” “Executive Compensation” and “Certain Relationships and Related Transactions.” To the extent that holdings of such participants in Oportun’s securities have changed since the amounts printed in the 2024 Proxy Statement, such changes have been reflected on the following filings: for Ms. Barefoot, on June 28, 2024; for Mr. Daswani, on June 28, 2024 and December 13, 2024; for Ms. Lee, on June 28, 2024; for Mr. Minetti, on June 28, 2024 and December 13, 2024; for Mr. Miramontes, on June 28, 2024; for Mr. Parker, on April 25, 2024June 18, 2024, and June 28, 2024; for Ms. Smith, on June 28, 2024; for Mr. Tambor, on June 28, 2024 and June 28, 2024; for Mr. Vazquez, on June 18, 2024September 12, 2024December 2, 2024March 12, 2025, and April 4, 2025; and for Mr. Williams, on June 28, 2024 and December 11, 2024.

    Promptly after filing its definitive 2025 Proxy Statement with the SEC, Oportun will mail the definitive 2025 Proxy Statement and a GREEN proxy card to each stockholder entitled to vote at the Annual Meeting. STOCKHOLDERS ARE URGED TO READ THE 2025 PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT OPORTUN WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders may obtain, free of charge, Oportun’s proxy statement (in both preliminary and definitive form), any amendments or supplements thereto, and any other relevant documents filed by Oportun with the SEC in connection with the Annual Meeting at the SEC’s website, which is located here. Copies of Oportun’s definitive 2025 Proxy Statement, any amendments or supplements thereto, and any other relevant documents filed by Oportun with the SEC in connection with the Annual Meeting will also be available, free of charge, at Oportun’s website, which is located here, or by writing to Investor Relations, Oportun Financial Corporation, 2 Circle Star Way, San Carlos, CA 94070. In addition, copies of these materials may be requested, free of charge, from Oportun’s proxy solicitor, Innisfree M&A Incorporated, by calling toll-free to (877) 800-5195.

    Investor Contact
    Dorian Hare
    (650) 590-4323
    ir@oportun.com

    Innisfree M&A Incorporated
    Scott Winter / Gabrielle Wolf / Jonathan Kovacs
    (212) 750-5833

    Media Contact
    John Christiansen / Bryan Locke
    FGS Global
    Oportun@fgsglobal.com

    The MIL Network

  • MIL-OSI USA: Kaptur, Bell, Quigley, Johnson Send Letter Opposing Ed Martin Nomination Over Russian Media Ties

    Source: United States House of Representatives – Congresswoman Marcy Kaptur (OH-09)

    Washington, DC — Representatives Marcy Kaptur (OH-09), Wesley Bell (MO-01), Mike Quigley (IL-05), and Hank Johnson (GA-04), led a letter to President Trump and Attorney General Pam Bondi raising serious concerns over the potential nomination of Ed Martin to serve as US Attorney for the District of Columbia. Congresswoman Kaptur is the Co-Founder and Co-Chair and Congressman Quigley serves as Democratic Co-Chair of the Congressional Ukraine Caucus, and Congressman Bell is a new member of the Caucus. Additionally, Congressman Johnson is a senior member of the House Judiciary Committee, and Congressman Bell previously served as St. Louis County Prosecuting Attorney, leading Missouri’s largest prosecutor’s office.

    The letter cites Martin’s extensive history of appearances on Russian state-funded media outlets RT and Sputnik — over 150 times in recent years — as cause for alarm given the sensitive nature of the role. The lawmakers argue that Martin’s public statements on these platforms, many of which were not disclosed,  have often echoed Kremlin propaganda and undermined US national security interests, particularly regarding Russia’s aggression in Ukraine.

    “Mr. Martin’s public contributions to Russian-backed platforms are deeply troubling to consider when considering how these views may reflect his stance toward critical issues related to Ukraine and national security. The downplaying of Russian aggression and interference in Ukraine he has espoused on Russian media raises concerns about his ability to uphold U.S. interests, particularly at a time when Russia’s invasion of Ukraine has escalated tensions globally. Additionally, his denying evidence of a Russian military buildup near Ukraine’s borders and suggesting that it was the US, not the Assad Regime, who ‘engineered’ the deadly 2017 Syrian chemical weapons attack. His appearances have included promoting narratives that align with Russian propaganda over US policy positions and our national interests,” said the lawmakers.

    “Crucially, Mr. Martin did not fully disclose his extensive involvement with RT and Sputnik as required on his Senate Judiciary Committee questionnaire. This failure in transparency regarding his associations with Russian-backed media outlets calls into question his judgment and commitment to serving the interests of the United States. The US government has consistently recognized RT and Sputnik as propaganda and intelligence tools of the Russian state, and his refusal to disclose his participation raises serious doubts about his loyalty to American values,” continued the lawmakers.

    “Given the gravity of these concerns, we urge you to conduct a thorough review of Mr. Martin’s past statements, associations, and overall fitness for the role of US Attorney for the District of Columbia. The appointment of an individual with such questionable allegiances could have serious repercussions for both US foreign policy and the integrity of our legal system,” concluded the lawmakers.

    Read the full text of the letter here.

    # # #

    MIL OSI USA News

  • MIL-OSI Global: Why south-east Asia must lead the fight against neglected tropical diseases

    Source: The Conversation – UK – By Tuck Seng Wong, Professor of Biomanufacturing, School of Chemical, Materials and Biological Engineering, University of Sheffield

    Village health Volunteers in Thailand survey mosquito breeding sites as part of dengue prevention campaign Deere Kumphaitoon/Shutterstock

    Neglected tropical diseases (NTDs) are a persistent public health threat, and tackling them is not just a moral obligation, but a smart investment.

    NTDs are a group of infectious diseases that mainly affect poor people in tropical and subtropical regions. These diseases are called “neglected” because they have received less attention and fewer resources than other major health issues, despite affecting over a billion people worldwide.

    NTDs disproportionately affect the poorest communities in low- and middle-income countries (LMICs) where they lock people in cycles of poverty by hindering physical and cognitive development, reducing school attendance and limiting economic productivity.

    Wealthier nations experience far lower rates of these diseases. Yet it’s in LMICs that cost-effective interventions like improved water, sanitation, hygiene and vector control – methods used to limit or eliminate insects that spread diseases to humans – can deliver the greatest return. According to the World Health Organization (WHO), every dollar invested in controlling and eliminating NTDs can yield up to US$25 (£19) in economic and health benefits, through lower healthcare costs, increased productivity and improved education outcomes.

    While vaccines are one of the most powerful tools for disease prevention, there are still no vaccines for most NTD. Progress has been slow, largely due to fragmented funding and limited investment in research. This gap continues to leave millions vulnerable.

    To address this, we helped establish the UK–South East Asia Vaccine Manufacturing Research Hub (UK-SEA Vax Hub) in 2023 to reduce the burden of infectious diseases in LMICs, with a special focus on south-east Asia. Its mission is to strengthen regional capacity in vaccine research, development and manufacturing. Dengue and rabies – both persistent NTDs – are among its priorities.

    The urgency of this work is underscored by the growing threat of dengue. Between 2015 and 2019, dengue cases rose by 46% in south-east Asia. Countries like Indonesia, Myanmar and Thailand are among the most affected globally. This region accounts for more than half of the world’s dengue cases.

    Dengue is hard to diagnose. Its symptoms – fever, rash and joint pain – overlap with other illnesses like chikungunya, Zika, malaria and typhoid. Misdiagnoses are common and no specific antiviral treatment exists.

    While vaccines are available, their use is limited by strict eligibility criteria based on age, infection history and local disease patterns. This leaves many people without protection.

    What’s urgently needed are more effective, affordable and widely accessible vaccines. But vaccines alone won’t solve the problem. Combatting dengue and other NTDs requires an integrated strategy, particularly in poor countries with limited health infrastructure.

    To stop the spread of diseases like dengue, it’s not enough to just treat people or use vaccines. You also need to control the insects that carry and spread the disease – in this case, mosquitoes.

    That includes actions like removing standing water where mosquitoes breed, using insecticides, or installing window screens and bed nets. These steps are essential to reducing infection rates and protecting communities. These interventions, driven by local action, are just as essential as biomedical advances. Together, they build a more sustainable and resilient defence against mosquito-borne diseases.

    For decades, public health initiatives in low-income countries were largely funded by wealthy countries – through development aid, international donors and philanthropic foundations. But with shifting global priorities and tightening budgets, it’s increasingly clear that this model is no longer sustainable.

    Long-term health security must be led from within. That means a shift in mindset. Low-income countries must see themselves not just as aid recipients, but as innovators, implementers and investors in their own health futures.

    This transition is already underway. The UK-SEA Vax Hub has evolved beyond its original research remit. By embedding its work within the broader regional health agenda, the hub is promoting government ownership and regional collaboration: critical steps in building stronger, more self-reliant health systems.

    While progress is promising, major challenges remain. One of the most pressing is the need to develop a new generation of public health leaders across south-east Asia – people who can lead research and development, champion vaccine production and help shape policy based on local needs. These leaders will be essential for ensuring that south-east Asia becomes not just a regional health player, but a global one.

    Another key challenge is regulatory. In a diverse region like south-east Asia, varying national policies can slow innovation and emergency responses. Streamlining and harmonising these systems is essential for responding quickly and effectively during future outbreaks or pandemics.

    South-east Asia has the potential to become a global hub for vaccine manufacturing. The region benefits from growing scientific and industrial capacity, relative political stability and a shared interest in tackling shared health threats. It also has a strong case to lead the fight against NTDs, which continue to disproportionately affect its populations.

    South-east Asia stands at a critical juncture. With strategic investment, regional leadership and cross-border collaboration, the region can protect its people, drive innovation and shape the future of global health.

    The fight against NTDs is more than a public health challenge – it’s a chance for south-east Asia to lead by example and redefine its role on the world stage.

    Tuck Seng Wong receives funding from the Department of Health and Social Care (DHSC) and the Engineering and Physical Sciences Research Council (EPSRC) for the UK-SEA Vax Hub.

    Kang Lan Tee receives funding from the Department of Health and Social Care (DHSC) and the Engineering and Physical Sciences Research Council (EPSRC) for the UK-SEA Vax Hub.

    ref. Why south-east Asia must lead the fight against neglected tropical diseases – https://theconversation.com/why-south-east-asia-must-lead-the-fight-against-neglected-tropical-diseases-255640

    MIL OSI – Global Reports

  • MIL-OSI USA: School of Nursing’s Sigma Theta Tau Mu Chapter Inducts 69 New Members

    Source: US State of Connecticut

    On April 27, UConn School of Nursing’s Sigma Theta Tau Mu Chapter held their annual induction ceremony. Undergraduate and graduate students, as well as nursing professionals and community leaders, were offered membership to the Honor Society. 

    In 1955, the UConn School of Nursing chartered Mu Chapter as the 11th chapter of Sigma Theta Tau International, the Honor Society of Nursing. There are now over 540 chapters internationally. 

    President Elizabeth Mayerson, DNP, RN, APRN, FNP-BC, CNE, presided over the ceremony. She explained “in the name of our honor society, Sigma represents love, Theta represents courage, and Tau represents honor. Our crest represents wisdom and discernment, service, professional endeavor, strength of leadership, and knowledge. Our key, which is represented on Sigma’s pin, denotes the satisfaction of professional life, the six founders, the lamp of knowledge, and our charge.” 

    UConn School of Nursing’s Sigma Theta Tau Mu Chapter 2025 induction ceremony. (Emily Laput)

    Based in Indianapolis, Sigma Theta Tau promotes scholarship and research in the field of nursing. The Mu Chapter hosts local meetings year-round and sends delegates to the society’s annual conferences at the regional, national, and international levels. It also supports exceptional research proposals through monetary awards provided by both the Mu Chapter and Sigma Theta Tau International. 

    “This is a really important and exciting part of your nursing journey,” Dean Victoria Vaughan Dickson, Ph.D., RN, FAHA, FHFSA, FAAN, shared with the inductees. “Many of you, if not all of you will be graduating soon, and that will mark you on your professional journey. This is a recognition of the academic excellence that you have brought to the School of Nursing, your commitment to service, and your leadership that we anticipate will continue throughout your professional career.” 

    The keynote address was delivered by Judith Hahn, Ph.D., RN, executive director of nursing professional practice and education at Yale New Haven Health System. She is also a graduate of the UConn SoN Ph.D. program.  

    “When I say leadership, many of you will think about the boardroom or wearing a managerial badge. But let me be clear, leadership in nursing starts long before the title does, it starts with a mindset, a commitment, a refusal to settle for average,” Hahn stated. “Which brings me to the University of Connecticut women’s basketball team. Both groups are forged in pressure, both are grounded in discipline, and most must be prepared to lead, not someday, but every day.” 

    Allison Villano at the SoN Sigma Theta Tau Mu Chapter 2025 induction ceremony. (Emily Laput)

    In 2025, the induction class consisted of 44 undergraduate students, 20 master’s students, and five doctoral students. Additionally, Sigma Mu Chapter recognized Nancy Dupont, UConn Health’s director of epidemiology, as a nurse leader.  

    “So as a member, I welcome you, as Dean, I want to extend my heartfelt congratulations for your accomplishments, and I also want to say that we are all proud of you as UConn nurses, and we look forward to seeing the many important and meaningful contributions you will make over the course of your career, both as a nurse, and now as a Sigma Honor Society member,” remarked Dickson. 

    2025 Sigma Inductees:

    Undergraduates

    • Skyler Arpin 
    • Michael Asante  
    • Courtney Balerna 
    • Nicole Ballas 
    • Alexa Bartoli 
    • Phoebe Bergstraser 
    • Melanie Bisbee 
    • Maria Bistras 
    • Molly Brett 
    • Kaitlynn Brito Torres 
    • Diamond Bussiere 
    • Abby Card 
    • Julia Cassano 
    • Logan Corey 
    • Katherine DeVito 
    • Sean Flaherty 
    • Tobias Fraedrich 
    • Gillian Fulton 
    • Amy Gabriel 
    • Madison Gaynor 
    • Flavia Heredia 
    • Esme Ho 
    • Khadija Ibrahim 
    • Brianna Iuteri 
    • Teresa Leopold 
    • Vincent Mascoli 
    • Luke Maynard 
    • Molly McElhinney 
    • Christy McEnroe 
    • Rohan Mistry 
    • Hailey Nardelli 
    • Olivia Orphanos 
    • Gifty Osei 
    • Skyler Phan 
    • Emi Rosenthal 
    • Madison Sastram 
    • Sherina Sauveur 
    • Allison Sidell 
    • Nicole Torres 
    • Allison Villano 
    • Daniel Ward 
    • Isabel Whelan 
    • Iris White 
    • Christina Yang

    Master’s Students

    • Brianna Arnold 
    • Brittany Barra 
    • Elizabeth Culbert 
    • Kimberly Davis 
    • Eleanor Dowd 
    • Stephanie Dumas 
    • Hillary Eisenberg 
    • Rachel Gold 
    • Emma Green 
    • Jawal Hage 
    • Nicole Hurler 
    • Kyle Kendall 
    • Paulina Obojski 
    • Pedro Ramirez 
    • Audrey Robertson 
    • Andrea Shirley 
    • Danielle Springer 
    • Emma Sullivan 
    • Salvatrice Tinsley 
    • Megan Wilmoth 

    Doctoral Students

    • Wilfred Elliam – PhD  
    • Laura Karwoski – DNP 
    • Anita Oppong – PhD 
    • Jennifer Pilchik – DNP 
    • Catherine Reilly – DNP 

    Nurse Leader

    • Nancy Dupont 

    MIL OSI USA News

  • MIL-OSI: Fortinet Expands Hybrid Mesh Firewall Portfolio with FortiGate 700G

    Source: GlobeNewswire (MIL-OSI)

    SUNNYVALE, Calif., May 07, 2025 (GLOBE NEWSWIRE) —

    Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced the FortiGate 700G series, a next-generation firewall (NGFW) purpose-built for the modern campus. Powered by Fortinet’s proprietary Network Processor 7 (NP7), Security Processor 5 (SP5) ASIC, and FortiOS, Fortinet’s unified operating system, the FortiGate 700G series delivers up to 7x higher firewall throughput, 4x better threat protection, and 7x lower power consumption than competitor offerings. With support for advanced networking, FortiGuard AI-Powered Security Services, and new FortiOS enhancements, including post-quantum cryptography readiness, FortiAI-Protect for AI-driven threat detection, and generative AI (GenAI) risk assessment, the FortiGate 700G helps organizations reduce risk, optimize performance, and future-proof hybrid IT environments.

    “With the FortiGate 700G series, we’re delivering more than just industry-leading performance that customers have come to expect from Fortinet—we’re equipping organizations with advanced capabilities to stay ahead of current and emerging cyberthreats,” said Nirav Shah, Senior Vice President, Products and Solutions, at Fortinet. “From AI-powered threat detection and GenAI risk mitigation with FortiAI-Protect to post-quantum cryptography readiness built into FortiOS, this new next-generation firewall series helps our customers consolidate infrastructure, reduce cyber risk, and confidently build for the future.”

    FortiGate 700G: Industry-leading Performance with AI-Powered Security
    Today’s enterprises are under pressure to scale operations, secure expanding attack surfaces, and manage increasingly sophisticated cyberthreats while reducing costs and maintaining efficiency. The FortiGate 700G series is engineered to meet these demands, offering:

    • Unmatched performance and security: Delivering 7x higher firewall throughput (164 Gbps) and 4x better threat protection (26 Gbps) than the industry average, the FortiGate 700G series ensures businesses maintain high-speed, secure operations.
    • Energy resilience through ultra-efficient design: The FortiGate 700G series enables continuous security even in energy-constrained or sustainability-focused environments. Consuming 7x fewer watts per Gbps than the industry average, the FortiGate 700G series sets the standard for energy efficiency and significantly reduces operational costs.
    • Enhanced threat detection and response with AI-powered security: As attackers increasingly weaponize AI and automate cyberattacks, FortiGuard AI-Powered Security Services, enhanced by FortiAI-Protect, enables organizations to detect and block emerging, unknown, and increasingly sophisticated threats. FortiAI-Protect also delivers contextual risk assessments and enforces access controls for third-party GenAI applications, providing visibility into shadow AI usage across business groups and helping improve the overall data security posture of organizations.
    • Post-quantum cryptography readiness: New FortiOS capabilities help protect sensitive data against quantum-era threats by enabling quantum-resistant encryption, algorithm stacking for enhanced protection, and a seamless transition to post-quantum security, ideal for organizations in finance, healthcare, government, and other sectors handling long-term sensitive information.
    • Support for a wide range of network interfaces, ranging from 5GE to 25GE: Ensuring the flexibility to connect various devices and topologies, the FortiGate 700G series enables organizations to seamlessly adapt to developing technologies and accommodate future upgrades without costly overhauls.
    • Deeper protections for critical system files: FortiSentry is a unique out-of-band hardware module that provides continuous, non-intrusive file-system monitoring, adding another layer of protection to detect and prevent unauthorized access to critical system files.
    Specification FortiGate
    700G
    series
    Security
    Compute
    Rating
    Industry
    Average
    Palo Alto
    Networks
    PA-3410
    series
    Check
    Point
    6700
    Cisco
    Secure
    Firewall
    3110
    Firewall Throughput 164 Gbps 7x 23.3 Gbps 14.0 Gbps 38.0 Gbps 18.0 Gbps
    IPsec VPN Throughput 55 Gbps 7x 7.7 Gbps 6.6 Gbps 4.6 Gbps 12.0 Gbps
    Threat Protection 26 Gbps 4x 6.7 Gbps 7.5 Gbps 5.8 Gbps
    Concurrent Sessions 16M 3x 6.5M 1.4M 16M 2M
    Connections/Second 700K 3x 231K 145K 250K 300K
    Power Consumption FortiGate
    700G
    series
    Energy
    Efficiency
    Industry
    Average
    Palo Alto
    Networks

    PA-3410
    series
    Check
    Point
    Quantum
    9200
    series
    Cisco
    Secure
    Firewall
    3100 series
    Watts/Gbps Firewall Throughput 1.8 W 7x 12.7 W 12.1 W 3.7 W 22.2 W
    Watts/Gbps IPsec VPN Throughput 5.4 W 6x 29.9 W 25.8 W 30.6 W 33.3 W
    • Threat Protection performance is measured with Firewall, IPS, Application Control and Malware Protection, and Logging enabled.
    • The numbers for competitive solutions are based on publicly available sources. Other vendors may have different testing methodologies.
    • All power consumption values are taken from external data sheets and hardware system guides using maximum power consumption.

    Fortinet Security Fabric: Powering a Unified and Scalable Cybersecurity Platform

    At the core of Fortinet’s approach is the belief that effective cybersecurity starts with the convergence of networking and security. The Fortinet Security Fabric, an integrated platform built on a common operating system and purpose-built technologies like the FortiGate 700G series, delivers consistent protection across hybrid environments. It empowers organizations with centralized management, automated threat intelligence, and real-time visibility. With seamless integration across Fortinet and third-party solutions, the Fortinet Security Fabric helps customers confidently scale from foundational network protection to advanced capabilities like SASE and AI-driven security operations. Fortinet continues to innovate and enable businesses to simplify complexity, reduce risk, and evolve their cybersecurity strategy with a platform approach that grows with them.

    Additional Resources

    About Fortinet
    Fortinet (Nasdaq: FTNT) is a driving force in the evolution of cybersecurity and the convergence of networking and security. Our mission is to secure people, devices, and data everywhere, and today we deliver cybersecurity everywhere our customers need it with the largest integrated portfolio of over 50 enterprise-grade products. Well over half a million customers trust Fortinet’s solutions, which are among the most deployed, most patented, and most validated in the industry. The Fortinet Training Institute, one of the largest and broadest training programs in the industry, is dedicated to making cybersecurity training and new career opportunities available to everyone. Collaboration with esteemed organizations from both the public and private sectors, including Computer Emergency Response Teams (“CERTS”), government entities, and academia, is a fundamental aspect of Fortinet’s commitment to enhance cyber resilience globally. FortiGuard Labs, Fortinet’s elite threat intelligence and research organization, develops and utilizes leading-edge machine learning and AI technologies to provide customers with timely and consistently top-rated protection and actionable threat intelligence. Learn more at https://www.fortinet.com, the Fortinet Blog, and FortiGuard Labs.

    Copyright © 2025 Fortinet, Inc. All rights reserved. The symbols ® and ™ denote respectively federally registered trademarks and common law trademarks of Fortinet, Inc., its subsidiaries and affiliates. Fortinet’s trademarks include, but are not limited to, the following: Fortinet, the Fortinet logo, FortiGate, FortiOS, FortiGuard, FortiCare, FortiAnalyzer, FortiManager, FortiASIC, FortiClient, FortiCloud, FortiMail, FortiSandbox, FortiADC, FortiAI, FortiAIOps, FortiAgent, FortiAntenna, FortiAP, FortiAPCam, FortiAuthenticator, FortiCache, FortiCall, FortiCam, FortiCamera, FortiCarrier, FortiCASB, FortiCentral, FortiCNP, FortiConnect, FortiController, FortiConverter, FortiCSPM, FortiCWP, FortiDAST, FortiDB, FortiDDoS, FortiDeceptor, FortiDeploy, FortiDevSec, FortiDLP, FortiEdge, FortiEDR, FortiExplorer, FortiExtender, FortiFirewall, FortiFlex FortiFone, FortiGSLB, FortiGuest, FortiHypervisor, FortiInsight, FortiIsolator, FortiLAN, FortiLink, FortiMonitor, FortiNAC, FortiNDR, FortiPAM, FortiPenTest, FortiPhish, FortiPoint, FortiPolicy, FortiPortal, FortiPresence, FortiProxy, FortiRecon, FortiRecorder, FortiSASE, FortiScanner, FortiSDNConnector, FortiSIEM, FortiSMS, FortiSOAR, FortiSRA, FortiStack, FortiSwitch, FortiTester, FortiToken, FortiTrust, FortiVoice, FortiWAN, FortiWeb, FortiWiFi, FortiWLC, FortiWLM, FortiXDR and Lacework FortiCNAPP. Other trademarks belong to their respective owners. Fortinet has not independently verified statements or certifications herein attributed to third parties and Fortinet does not independently endorse such statements. Notwithstanding anything to the contrary herein, nothing herein constitutes a warranty, guarantee, contract, binding specification or other binding commitment by Fortinet or any indication of intent related to a binding commitment, and performance and other specification information herein may be unique to certain environments.

    The MIL Network

  • MIL-OSI Russia: Rosneft volunteers improved more than 50 monuments to the heroes of the Great Patriotic War on the eve of the Victory Day anniversary

    Translation. Region: Russian Federal

    Source: Rosneft – Rosneft – An important disclaimer is at the bottom of this article.

    In anticipation of the 80th anniversary of the Great Victory, volunteers from Rosneft enterprises renovated and improved more than 50 monuments, memorials, obelisks, commemorative signs, and burial sites of heroes of the Great Patriotic War in different parts of Russia.

    In the regions where the Company operates, employees take an active part in commemorative events dedicated to the anniversary of the Great Victory.

    Volunteers from the Central Office and Moscow enterprises of Rosneft have landscaped the area around the monument to the workers of the Moscow Oil Depot who died on the fronts of the Great Patriotic War. In 1941-1945, the oil depot, located on Sormovskaya Street in Moscow, played a key role in supplying the capital with fuel, ensuring uninterrupted supplies of fuel for military equipment. The Company’s employees installed new stone vases near the monument and planted flower beds. The wall of the oil depot was decorated with a mural dedicated to the contribution of oil workers to the Victory.

    Environmentalists and activists of the Novokuibyshevsky and Kuibyshevsky Oil Refineries, the Novokuibyshevsk Petrochemical Company and the Novokuibyshevsky Oil and Additives Plant, together with volunteers from the EcoRavnovesie movement, improved the park in the village of Kryazh in the Samara urban district. There is a monument to soldiers who died during the Great Patriotic War. Volunteers collected and removed household waste from the area, laid out flower beds and planted a rowan alley.

    Employees of the Kuibyshev Oil Refinery have improved more than a dozen burial sites of veterans of the Great Patriotic War in the Kuibyshev District of Samara. The oil workers cleaned the graves of the front-line soldiers after the winter and painted the fences.

    Volunteers of the Novokuibyshevsk Oil Refinery improved the Victory Alley and the area adjacent to the monument to home front workers. The memorial was erected in Novokuibyshevsk in 2022 on the initiative and with the support of the enterprise. In addition, the plant workers restored four burial sites of fellow countrymen – participants in the Great Patriotic War, installed new monuments, and improved the adjacent territories.

    Samaraneftegaz employees tidied up the monument to fallen heroes of the Great Patriotic War in the village of Mirny in the Samara Region. Volunteers cleaned up, painted the fences, and planted bushes and trees.

    In the Republic of Bashkortostan, in the city of labor valor Ishimbay, Bashneft volunteers together with activists of the Movement of the First improved the territory of the memorial to the Ishimbay oil workers who died in battles for the Motherland. The participants of the action collected and removed more than a ton of dead wood and household waste, painted the curbs and tree trunks.

    For several years, RN-Krasnodarneftegaz employees have been looking after the monument to the residents of the 2nd Zapadny farmstead in the Krymsky District of Krasnodar Krai. The fascist occupiers destroyed the farmstead along with all its residents in May 1943. Their memory is carefully preserved by Rosneft volunteers, who have taken patronage over the monument.

    In addition, RN-Krasnodarneftegaz volunteers tidied up the territory of the Monument to the Separate 16th Rifle Brigade in the village of Sputnik in the Seversky District of the Krasnodar Territory, the Memorial to those killed in the battles for the liberation of the village of Saratovskaya, the cultural heritage site “Mass grave of 52 Soviet soldiers killed in battles with the fascist invaders in 1943” in the Khankov farm in the Slavyansky District, the Victory Obelisk and the Worship Cross at the site of the death of Soviet citizens.

    According to a long-standing tradition, employees of the Tuapse Oil Refinery improved the monument to oil refiners who died during the Great Patriotic War and cleaned up the territory of Victory Park in Tuapse.

    Volunteers of the Ryazan NPK improved three memorial sites: a memorial in the village of Nikulichi in honor of the villagers who fought in the Great Patriotic War, a street named after the Hero of the Soviet Union and National Hero of Italy, a native of the Ryazan region, Fyodor Poletaev, and a monument to the pilots who died in an unequal battle with the enemy at the end of 1941.

    Udmurtneft employees together with activists of the Movement of the First improved the monument to those killed in the Great Patriotic War in the village of Svetloye in the Votkinsk district of Udmurtia. The company’s volunteers also participated in the arrangement of memorials in six settlements in the Sarapul, Sharkansky and Igrinsky districts of the republic.

    A large-scale volunteer initiative to improve war memorials was carried out by RN-Service employees. They tidied up the monuments to soldiers who died in Moscow hospitals and to fallen soldiers of the Kremlin Regiment. In Ufa, volunteers looked after individual burials in city and rural cemeteries. In Krasnoyarsk, oil workers improved the monument to “Soldiers-athletes of the Krasnoyarsk Territory – participants in the Great Patriotic War”. In Nefteyugansk, the monument to “Loyal Sons of the Fatherland” was renovated. In Buzuluk, work was carried out at the memorial to “Mass grave of soldiers of the Czechoslovak People’s Army” and at the burial sites of veterans. In the village of Kolva in the Komi Republic, the “Memorial sign to soldiers of the Great Patriotic War of 1941-1945” was improved. In the village of Sernovodsk in the Samara Region, the monument to “Defenders of all generations” was tidied up. In all regions, the patriotic event ended with the ceremonial laying of wreaths and a minute of silence.

    Volunteers from Voronezhnefteprodukt organized the cleanup of the military burial ground in the village of Chertovitsy, Ramonsky District, Voronezh Region. 383 soldiers who died of wounds in hospitals in 1942-1943 are buried here.

    Workers of Kaluga Oil Products cleared and landscaped the area around the memorial sign to pilots near the village of Kosmachi in the Babyninsky District of the Kaluga Region. The sign was installed 10 years ago at the site of the heroic death of the Pe-2 aircraft crew in 1941.

    Employees of RN-North-West take care of the memorial to the sailors of the warship TShch-100 who died there, guarding the “Road of Life” during the siege of Leningrad. The memorial is located in the village of Vladimirovka in the Priozersky District of the Leningrad Region.

    For several years now, Orelnefteprodukt employees have been patronizing a mass grave in the village of Gnilets, Trosnyansky District, Oryol Region. Here are buried 427 soldiers of the 1st Battalion, 605th Infantry Regiment, 132nd Infantry Division, who died in the fiercest battles on the Northern Face of the Kursk Bulge on July 7, 1943. This year, in honor of the Victory anniversary, volunteers have decorated a flower bed in the form of a St. George ribbon on the territory of the Vyazhi military-historical complex in the Novosilsky District, Oryol Region, where the offensive operation to liberate Oryol began in July 1943.

    Rosneft supports projects and initiatives aimed at preserving the historical memory of the immortal feat of the Soviet people during the Great Patriotic War.

    Department of Information and Advertising of PJSC NK Rosneft May 7, 2025

    Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

    MIL OSI Russia News

  • MIL-OSI Global: The MMR vaccine doesn’t contain ‘aborted fetus debris’, as RFK Jr has claimed. Here’s the science

    Source: The Conversation – Global Perspectives – By Hassan Vally, Associate Professor, Epidemiology, Deakin University

    Robert F. Kennedy Jr, the United States’ top public health official, recently claimed some religious groups avoid the measles, mumps and rubella (MMR) vaccine because it contains “aborted fetus debris” and “DNA particles”.

    The US is facing its worst measles outbreaks in years with nearly 900 cases across the country and active outbreaks in several states.

    At the same time, Kennedy, secretary of the Department of Health and Human Services, continues to erode trust in vaccines.

    So what can we make of his latest claims?

    There’s no fetal debris in the MMR vaccine

    Kennedy said “aborted fetus debris” in MMR vaccines is the reason many religious people refuse vaccination. He referred specifically to the Mennonites in Texas, a deeply religious community, who have been among the hardest hit by the current measles outbreaks.

    Many vaccines work by using a small amount of an attenuated (weakened) form of a virus, or in the case of the MMR vaccine, attenuated forms of the viruses that cause measles, mumps and rubella. This gives the immune system a safe opportunity to learn how to recognise and respond to these viruses.

    As a result, if a person is later exposed to the actual infection, their immune system can react swiftly and effectively, preventing serious illness.

    Kennedy’s claim about fetal debris specifically refers to the rubella component of the MMR vaccine. The rubella virus is generally grown in a human cell line known as WI-38, which was originally derived from lung tissue of a single elective abortion in the 1960s. This cell line has been used for decades, and no new fetal tissue has been used since.

    Certain vaccines for other diseases, such as chickenpox, hepatitis A and rabies, have also been made by growing the viruses in fetal cells.

    These cells are used not because of their origin, but because they provide a stable, safe and reliable environment for growing the attenuated virus. They serve only as a growth medium for the virus and they are not part of the final product.

    You might think of the cells as virus-producing factories. Once the virus is grown, it’s extracted and purified as part of a rigorous process to meet strict safety and quality standards. What remains in the final vaccine is the virus itself and stabilising agents, but not human cells, nor fetal tissue.

    So claims about “fetal debris” in the vaccine are false.

    It’s also worth noting the world’s major religions permit the use of vaccines developed from cells originally derived from fetal tissue when there are no alternative products available.

    Are there fragments of DNA in the MMR vaccine?

    Kennedy claimed the Mennonites’ reluctance to vaccinate stems from “religious objections” to what he described as “a lot of aborted fetus debris and DNA particles” in the MMR vaccine.

    The latter claim, about the vaccine containing DNA particles, is technically true. Trace amounts of DNA fragments from the human cell lines used to produce the rubella component of the MMR vaccine may remain even after purification.

    However, with this claim, there’s an implication these fragments pose a health risk. This is false.

    Any DNA that may be present in this vaccine exists in extremely small amounts, is highly fragmented and degraded, and is biologically inert – that is, it cannot cause harm.

    Even if, hypothetically, intact DNA were present in the vaccine (which it’s not), it would not have the capacity to cause harm. One common (but unfounded) concern is that foreign DNA could integrate with a person’s own DNA, and alter their genome.

    Introducing DNA into human cells in a way that leads to integration is very difficult. Even when scientists are deliberately trying to do this, for example, in gene therapy, it requires precise tools, special viral delivery systems and controlled conditions.

    It’s also important to remember our bodies are exposed to foreign DNA constantly, through food, bacteria and even our own microbiome. Our immune system routinely digests and disposes of this material without incorporating it into our genome.

    This question has been extensively studied over decades. Multiple health authorities, including Australia’s Therapeutic Goods Administration, have addressed the misinformation regarding perceived harm from residual DNA in vaccines.

    Ultimately, the idea that fragmented DNA in a vaccine could cause genetic harm is false.

    The bottom line

    Despite what Kennedy would have you believe, there’s no fetal debris in the MMR vaccine, and the trace amounts of DNA fragments that may remain pose no health risk.

    What the evidence does show, however, is that vaccines like the MMR vaccine offer excellent protection against deadly and preventable diseases, and have saved millions of lives around the world.

    Hassan Vally does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    ref. The MMR vaccine doesn’t contain ‘aborted fetus debris’, as RFK Jr has claimed. Here’s the science – https://theconversation.com/the-mmr-vaccine-doesnt-contain-aborted-fetus-debris-as-rfk-jr-has-claimed-heres-the-science-255718

    MIL OSI – Global Reports

  • MIL-OSI Global: Measles could again become widespread as cases surge worldwide

    Source: The Conversation – USA – By Rebecca Schein, Assistant Professor of Infectious Disease Pediatrics, Michigan State University

    Measles is one of the most infectious diseases on the planet. Kateryna Kon/Science Photo Library via Getty Images

    Globally, measles is on the rise across the U.S., Canada, Mexico, South America and parts of Europe. In 2025, North and South America saw 11 times more cases than during the same period last year. In Europe, measles rates are at their highest point in 25 years.

    In the U.S., as of May 2, 2025, health authorities have confirmed 935 cases of measles affecting 30 states. This is a huge surge compared with the 285 cases reported in 2024. A large measles outbreak is happening in Canada, too, with over 1,000 cases.

    The Conversation asked Rebecca Schein, a specialist in pediatric infectious diseases, to explain what this spike at home and abroad might mean for a disease that was declared eliminated from the U.S. in 2000.

    How do measles cases this year compare with previous years?

    From 2000 to 2010, less than 100 measles cases were reported each year in the U.S. Since 2010, there have been isolated outbreaks, mainly in unvaccinated communities, with approximately 200 to 300 cases a year. The latest major outbreak in the U.S. was in 2019, with 1,274 cases, primarily in the New York City metropolitan area and parts of New Jersey.

    Cases fell in 2020 to 2023 during the COVID-19 pandemic, returning to prepandemic levels in 2024. Currently, most U.S. cases are coming from an epidemic in Texas, with 702 confirmed cases as of May 6. Of these, 91 people were hospitalized and three people, two of them children, died. Measles cases are still being reported. Texas is one of 12 measles outbreaks documented in the U.S. in 2025 to date.

    The World Health Organization has declared both North and South America to be at high risk for measles. Canada reported a total of 1,177 cases as of April 19, with 951 of them linked to an outbreak that began in New Brunswick in October 2024 and spread to seven provinces. In 2023, there were 12 measles cases in all of Canada.

    Mexico reported 421 confirmed measles cases as of April 18, and another 384 cases are under investigation. There are also small measles outbreaks in South America, with Belize reporting its first two cases since 1991. Brazil reported five cases, and in Argentina there are 21 confirmed cases of measles, mainly in the capital city of Buenos Aires.

    U.S. exports these days include measles.

    In Europe, measles cases rose tenfold, hitting 35,212 in 2024, according to the European Centre for Disease Prevention and Control.

    How did the US eliminate measles?

    Measles is one of the most contagious infections ever identified. One person with measles can spread the infection to 12 to 18 others. That number, which epidemiologists call R0, is 1 to 4 for the flu and 2 to 5 for COVID-19.

    In 1912, measles became a nationally reportable disease tracked by all the health departments in the U.S. At that time, there were about 3 million to 4 million cases and 6,000 deaths each year in the country. Medical care improved and the death rate decreased, but cases spiked to epidemic levels every two to three years.

    It was not until 1963, when the first measles vaccine became widely available, that cases dropped dramatically. The current measles vaccine, which is called the MMR vaccine because it also includes vaccines against mumps and rubella, was released in 1971. In 1977, the U.S. government launched the National Childhood Immunization Initiative to ensure that school children received vaccination against polio, diphtheria, pertussis, tetanus, mumps, rubella and measles. Vaccination rates in children starting elementary school rose to 96% by 1981. Beginning in 1993, the Vaccines for Children program helped ensure that every child could receive vaccinations regardless of ability to pay.

    Vaccination programs were a resounding success. By 2000, measles cases arising in the U.S. had fallen to zero, with infections occurring only in people who traveled abroad. That year, the Centers for Disease Control and Prevention declared that measles was eliminated in the country.

    Why are rising measles rates so worrisome?

    Measles is a virus, like the common cold. Unlike bacterial infections, which can be treated with antibiotics, viral infections are typically not treatable but can often be prevented through vaccination programs.

    Vaccination stimulates the body’s immune system to make antibodies to fight a specific infection. For most people, just one dose of the measles vaccine protects them from infection. The second dose helps ensure long-term protection. Measles is so infectious that 95% of the population must be vaccinated to protect the community, a concept called herd immunity.

    A man holds a sign at a rally for science in St. Paul, Minn., on March 7, 2025.
    Universal Images Group via Getty Images

    During the past 20 years, however, vaccination rates are decreasing globally, with an especially sharp drop during the pandemic from limited exposure to medical care. Aligned with this trend, measles cases in the U.S. have been rising. As a result, some infectious disease experts worry that measles is heading toward becoming a common infection again.

    What happens if measles rates continue to rise?

    Public health officials define endemic infections as being consistently present within a region. For example, the common cold and now COVID-19 are endemic in the U.S.

    A higher-than-normal number of cases in an area is termed an outbreak. For measles, an outbreak is defined as more than three cases in a county or local area. When cases from an outbreak spread outside the local area, that is an epidemic, and if an epidemic spreads into many countries across the world, it becomes a pandemic.

    The measles outbreak in Texas started in January 2025 as an outbreak in six counties and quickly reached epidemic levels, hitting a total of 29 counties and a count of 702 cases as of May 6.

    A 2022 study used a computer algorithm to model the trajectory of measles cases in the U.S. given the drop in vaccination rates during the pandemic. If children who missed vaccines due to the pandemic do not receive catch-up vaccinations, and vaccine hesitancy continues at current rates, the study found, then 21% of U.S. children – about 15 million – will be vulnerable to measles over the following five years. That is well below the number needed to prevent measles outbreaks.

    A study using a similar approach published in April 2025 found that measles is likely to become endemic again in the U.S. and predicted that the country could experience 850,000 cases over the next 25 years if vaccination rates remain the same. If vaccine rates decrease further, the study found, case numbers could increase to 11 million over the next 25 years.

    What would it take to reverse the rise in measles?

    Reversing this trend will require steadily increasing community vaccination rates. The April 2025 study found that boosting community vaccination rates by 5% would tamp down the increase in cases to between 3,000 and 19,000 over the next 25 years.

    Another epidemiological model that estimates measles spread, published in February, predicted that by intervening early in an outbreak with local health department support, measles outbreaks can be contained as long as 85% of the population is vaccinated against the disease.

    That, of course, requires ensured ongoing access to free and accessible childhood vaccinations and restoration of the public’s trust in measles vaccines.

    Rebecca Schein does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    ref. Measles could again become widespread as cases surge worldwide – https://theconversation.com/measles-could-again-become-widespread-as-cases-surge-worldwide-255501

    MIL OSI – Global Reports

  • MIL-OSI Asia-Pac: Central Council for Research in Ayurvedic Sciences revives two rare Ayurvedic manuscripts: Dravyaratnākara Nighaṇṭu and Dravyanamākara Nighaṇṭu

    Source: Government of India

    Central Council for Research in Ayurvedic Sciences revives two rare Ayurvedic manuscripts: Dravyaratnākara Nighaṇṭu and Dravyanamākara Nighaṇṭu

    Manuscripts will inspire scholarly exploration and deeper engagement with India’s classical medical literature

    Posted On: 07 MAY 2025 2:44PM by PIB Delhi

    In a significant stride toward preserving India’s rich legacy in traditional medicine, the Central Council for Research in Ayurvedic Sciences (CCRAS), under the Ministry of Ayush, has revived two rare and significant Ayurvedic manuscripts—Dravyaratnākara Nighaṇṭu and Dravyanamākara Nighaṇṭu.

    The publications are unveiled during an event organised by the RRAP Central Ayurveda Research Institute in Mumbai. The event was graced by Prof. Vd. Rabinarayan Acharya, Director General, CCRAS, New Delhi, who also delivered the keynote address highlighting the ‘Activities of CCRAS, Ministry of Ayush’, in research, digitisation, and revival of traditional Ayurvedic literature.

    The manuscripts were critically edited and translated by renowned manuscriptologist and veteran Ayurveda expert, Dr. Sadanand D. Kamat of Mumbai. The release ceremony saw the presence of dignitaries, including Shri Ranjit Puranik, President, Ayurvidya Prasarak Mandal and Managing Director, Shri Dhootapeshwar Limited; Dr. Ravi More, Principal, Ayurveda Mahavidyalaya, Sion; Dr. Shyam Nabar and Dr. Ashanand Sawant from Ayurvidya Prasarak Mandal; and Dr. R. Govind Reddy, Assistant Director (Ayu), CARI, Mumbai.

    Speaking on the occasion, Prof. Vd. Rabinarayan Acharya emphasised the importance of such revivals in bridging India’s ancient wisdom with contemporary research frameworks. He said that “These texts are not just historical artefacts—they are living knowledge systems that can transform contemporary healthcare approaches when studied and applied thoughtfully”.

    These critical editions are expected to serve as invaluable resources for students, researchers, academicians, and Ayurveda practitioners, further inspiring scholarly exploration and deeper engagement with India’s classical medical literature.

    About the Manuscripts

    Dravyaratnākara Nighaṇṭu:

    Authored by Mudgala Paṇḍita in 1480 AD, this previously unpublished lexicon consists of eighteen chapters offering in-depth knowledge on drug synonyms, therapeutic actions, and medicinal properties. A widely referenced text in Maharashtra until the 19th century, it draws from classical Nighaṇṭus like Dhanvantari and Raja Nighaṇṭu while documenting numerous novel medicinal substances from plant, mineral, and animal origins. This critical edition, revived by Dr. S. D. Kamat, is a monumental contribution to Dravyaguna and allied Ayurvedic disciplines.

    Dravyaratnākara Nighaṇṭu—a revived 15th-century Ayurvedic lexicon

    Dravyanamākara Nighaṇṭu:

    Attributed to Bhisma Vaidya, this unique work serves as a standalone appendix to the Dhanvantari Nighaṇṭu, focusing exclusively on homonyms of drug and plant names—a complex area of study vital to Ayurveda. Encompassing 182 verses and two colophon verses, the text has been meticulously edited and commented upon by Dr. Kamat, enhancing its utility for scholars of Rasashastra, Bhaishajya Kalpana, and classical Ayurvedic pharmacology.

    Dr. Kamat, known for his authoritative work on Saraswati Nighaṇṭu, Bhāvaprakāsha Nighaṇṭu, and Dhanvantari Nighaṇṭu, once again brings his deep scholarship and commitment to preserving India’s Ayurvedic heritage.

    Dravyanāmākara Nighaṇṭu—an erudite supplement to Dhanvantari Nighaṇṭu, exploring Ayurvedic homonyms with precision

    These critical editions are more than scholarly achievements; they are beacons for future Ayurvedic practitioners, researchers, and educators. By digitising, editing, and interpreting these works, CCRAS and its collaborators are not only safeguarding literary treasures but also enriching India’s traditional healthcare system with validated ancient insights.

    ****

    MV/AKS

    (Release ID: 2127487) Visitor Counter : 93

    MIL OSI Asia Pacific News

  • MIL-Evening Report: More than 50 years after trying to reach Venus, a failed Soviet spacecraft is about to return to Earth

    Source: The Conversation (Au and NZ) – By Alice Gorman, Associate Professor in Archaeology and Space Studies, Flinders University

    A postage stamp from the Soviet Union celebrating its Venus space program from the 1960s and 1970s. Soviet Union/Wikipedia

    During the height of the Cold War in the 1960s and 1970s, the USSR launched 29 spacecraft towards Venus, the planet scientists call Earth’s “twin sister”.

    Three flew past Venus, and went into orbit around the Sun. Sixteen orbited or landed on Venus, where they experienced a climate often described as “hellish”.

    Ten got stuck in Earth orbit. All of them re-entered Earth’s atmosphere the same year they were launched – except Kosmos 482, which has stayed aloft for 53 more years. As the last remnant of the Soviet Venus program left in Earth orbit, it’s not your average piece of space junk.

    Because it was designed to withstand Venusian conditions, many think the lander may make planetfall on Earth instead of incinerating in the atmosphere. And that is expected to happen this week.

    Destination Morning Star

    Venus was a target of interest because its thick clouds might be hiding life on the surface. But the spacecraft were also Cold War weapons aimed at demonstrating the superiority of socialist science.

    Venera 1 was launched in 1961, only four years after Sputnik 1, the first satellite. Venera 7, in 1970, was the first spacecraft to successfully soft-land instead of crashing on a planet. Vega 2 was the last USSR Venus mission in 1984.

    The Venera probes were launched in pairs, a few days apart. If one failed, the other might succeed. Venera 8 was launched on March 27 1972 and reached Venus 117 days later. On March 31, its twin left Earth but failed to escape Earth orbit, earning the designation Kosmos 482.

    Venera 8 (pictured here) was identical to Kosmos 482 and made it to Venus.
    Lavochkin/Roscosmos/Wikipedia

    The spacecraft comprised a delivery “bus” about 3.5 metres tall, with a propulsion system, solar panels and a mesh dish antenna at one end, and the spherical landing craft at the other end. The landers had their own refrigeration system to cool them down and a heat shield to protect them. If all went to plan, the buses would eject the landers from orbit. The landers would hit the upper cloud decks at a speed of nearly 12km per second.

    At 60km altitude, the main parachute was released to float the lander down to the surface. A range of instruments would then measure the temperature, pressure, wind speed, visibility, atmospheric gases and rock composition, and radio the results back to Earth. Each lander carried a USSR medallion inside.

    But all didn’t go to plan. Venera 8 sped on its way to Venus, sending its lander down on July 22.

    Fate had something different in store for Kosmos 482.

    How to be space junk in one easy step

    The upper rocket stage that was meant to propel the Kosmos 482 bus out of Earth orbit shut off too early because the timer wasn’t set correctly. The rocket stage fell back to Earth and burnt up, while titanium pressure vessels from its fuel system fell onto fields in Aotearoa New Zealand.

    The bus and landing craft came apart in mid-June and the bus fell back into the atmosphere in 1981. The 465kg lander continued its orbit alone.

    At its farthest, the lander was 9,000km away, coming as close as 210km in its highly elliptical orbit around Earth. Over 50 years, that orbit has lowered to only 2,000km at its farthest point. Now the atmosphere is dragging it back towards Earth with a predicted re-entry of May 10. You can get updates on Kosmos 482’s position here.

    Venera 9 took the first images of the surface in 1975. The Venera 13 and 14 missions took the first colour photos.

    Will the lander fall on Earth?

    The lander had a titanium body designed to withstand Venus surface conditions of 90 times the atmospheric pressure of Earth and 470°C. After more than 50 years it won’t have the refrigeration, the capacity to aerobrake or a working parachute to slow it down and keep it cool. Its reentry will be uncontrolled.

    Typically, space junk reenters at around seven kilometres per second and can reach temperatures of 1,600°C as it tears through the atmosphere. Titanium alloys have a melting point of around 1,700°C. This is why the so-called “space balls” that landed in New Zealand in April 1972 survived reentry. If they did, then the lander could as well.

    Six of the nine other failed Kosmos reentries had landers or impactors, but we don’t know where they are – either they did not survive, fell into the ocean, or have not yet been found on land. This may also be the fate of the Kosmos 482 lander.

    The Kosmos 482 lander filmed from Leiden in 2020 by space tracking expert Marco Langbroek (Delft Technical University)

    Danger from Venus

    Venus might be the planet of love, but in popular culture, it has been associated with danger.

    In the 1960 East German film The Silent Star (later dubbed into English as First Spaceship on Venus), the Venusians plan to bombard Earth with radiation so they can conquer it.

    In the 1968 film Night of the Living Dead, an American Venus probe returns bringing a deadly radiation which turns the dead into zombies.

    An episode of the hit 1970s TV series The Six Million Dollar Man characterised a Russian Venus spacecraft as a “death probe” when it accidentally returned to Earth.

    These representations reflect Cold War fears of nuclear war and war waged from space.

    In the 21st century, we have a new source of anxiety: the environmental impacts of space junk. But spacecraft such as Kosmos 482 are not the junk people should be worried about.

    In the past five years, there’s been a massive increase in the number of rocket launches and the number of spacecraft in low Earth orbit. More and more space junk is reentering the atmosphere. For example, it’s estimated that a Starlink satellite reenters almost every day. When it burns up, it leaves behind damaging chemicals and soot particles.

    In the meantime, Venera 8 is still waiting silently on the surface of Venus for its twin to arrive.

    Alice Gorman is an expert member of the International Council on Monuments and Sites (ICOMOS) International Scientific Committee on Aerospace Heritage and a Fellow of the Outer Space Institute.

    ref. More than 50 years after trying to reach Venus, a failed Soviet spacecraft is about to return to Earth – https://theconversation.com/more-than-50-years-after-trying-to-reach-venus-a-failed-soviet-spacecraft-is-about-to-return-to-earth-255836

    MIL OSI AnalysisEveningReport.nz

  • MIL-Evening Report: COVID is still around and a risk to vulnerable people. What are the symptoms in 2025? And how long does it last?

    Source: The Conversation (Au and NZ) – By Meru Sheel, Associate Professor and Epidemiologist, Infectious Diseases, Immunisation and Emergencies (IDIE) Group, Sydney School of Public Health, University of Sydney

    Five years ago, COVID was all we could think about. Today, we’d rather forget about lockdowns, testing queues and social distancing. But the virus that sparked the pandemic, SARS-CoV-2, is still circulating.

    Most people who get COVID today will experience only a mild illness. But some people are still at risk of severe illness and are more likely to be hospitalised with COVID. This includes older people, those who are immunocompromised by conditions such as cancer, and people with other health conditions such as diabetes.

    Outcomes also tend to be more severe in those who experience social inequities such as homelessness. In the United Kingdom, people living in the 20% most deprived areas have double chance of being hospitalised from infectious diseases than those in the least deprived areas.

    How many cases and hospitalisations?

    In Australia, 58,000 COVID cases have been reported so far in 2025. However, testing rates have declined and not all positive cases are reported to the government, so case numbers in the community are likely much higher.

    Latest data from FluCan, a network of 14 hospitals, found 781 people were hospitalised for COVID complications in the first three months of the year. This “sentinel surveillance” data gives a snapshot from a handful of hospitals, so the actual number of hospitalisations across Australia is expected to be much higher.

    While deaths are lower than previous years, 289 people died from COVID-related respiratory infections in the first two months of the year.

    What can we expect as we head into winter?

    We often see an increase in respiratory infections in winter.

    However, COVID peaks aren’t just necessarily seasonal. Over the past few years, peaks have tended to appear around every six months.

    What are the most common COVID symptoms?

    Typical early symptoms of COVID included fever, cough, sore throat, runny nose and shortness of breath. These have remained the most common COVID symptoms across the multiple variant waves.

    Early in the pandemic, we realised COVID caused a unique symptom called anosmia – the changed sense of taste or smell. Anosmia lasts about a week and in some cases can last longer.
    Anosmia was more frequently reported from infections due to the ancestral, Gamma, and Delta variants but not for the Omicron variant, which emerged in 2021.

    However, loss of smell still seems to be associated with some newer variants. A recent French study found anosmia was more frequently reported in people with JN.1.

    But the researchers didn’t find any differences for other COVID symptoms between older and newer variants.

    Should you bother doing a test?

    Yes. Testing is particularly important if you experience COVID-like symptoms or were recently exposed to someone with COVID and are at high-risk of severe COVID. You might require timely treatment.

    If you are at risk of severe COVID, you can see a doctor or visit a clinic with point-of-care testing services to access confirmatory PCR (polymerase chain reaction) testing.

    Rapid antigen tests (RATs) approved by Australia’s regulator are also still available for personal use.

    But a negative RAT doesn’t mean that you don’t have COVID – especially if you are symptomatic.




    Read more:
    COVID-19 rapid tests still work against new variants – researchers keep ‘testing the tests,’ and they pass


    If you do test positive, while you don’t have to isolate, it’s best to stay at home.

    If you do leave the house while experiencing COVID symptoms, minimise the spread to others by wearing a well-fitted mask, avoiding public places such as hospitals and avoiding contact with those at higher risk of severe COVID.

    How long does COVID last these days?

    In most people with mild to moderate COVID, it can last 7–10 days.

    Symptomatic people can spread the infection to others from about 48 hours before you develop symptoms to about ten days after developing symptoms. Few people are infectious beyond that.

    But symptoms can persist in more severe cases for longer.

    A UK study which tracked the persistence of symptoms in 5,000 health-care workers found symptoms were less likely to last for more than 12 weeks in subsequent infections.

    General fatigue, for example, was reported in 17.3% of people after the first infection compared with 12.8% after the second infection and 10.8% following the third infection.

    Unvaccinated people also had more persistent symptoms.




    Read more:
    How long are you infectious when you have coronavirus?


    Vaccinated people who catch COVID tend to present with milder disease and recover faster. This may be because vaccination prevents over-activation of the innate immune response.

    Vaccination remains the best way to prevent COVID

    Vaccination against COVID continues to be one of the most effective ways to prevent COVID and protect against it. Data from Europe’s most recent winter, which is yet to be peer reviewed, reports COVID vaccines were 66% effective at preventing symptomatic, confirmed COVID cases.

    Most people in Australia have had at least one dose of the COVID vaccine. But if you haven’t, people over 18 years of age are recommended to have a COVID vaccine.

    Boosters are available for adults over 18 years of age. If you don’t have any underlying immune issues, you’re eligible to receive a funded dose every 12 months.

    Boosters are recommended for adults 65–74 years every 12 months and for those over 75 years every six months.

    Adults over 18 years who are at higher risk because of weaker immune systems are recommended to get a COVID vaccine every 12 months and are eligible every six months.

    Check your status and eligibility using this booster eligibility tool and you can access your vaccine history here.

    A new review of more than 4,300 studies found full vaccination before a SARS-CoV-2 infection could reduce the risk of long COVID by 27% relative to no vaccination for the general adult population.

    With ongoing circulation of COVID, hybrid immunity from natural infection supplemented with booster vaccination can help prevent large-scale COVID waves.

    Meru Sheel receives funding from National Health and Medical Research Council and Department of Foreign Affairs and Trade. She serves on WHO’s Immunization and Vaccines Related Implementation Research Advisory Committee (IVIR-AC)

    ref. COVID is still around and a risk to vulnerable people. What are the symptoms in 2025? And how long does it last? – https://theconversation.com/covid-is-still-around-and-a-risk-to-vulnerable-people-what-are-the-symptoms-in-2025-and-how-long-does-it-last-253840

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI NGOs: People fleeing Zamzam camp arrive to overwhelmed humanitarian response in Tawila

    Source: Médecins Sans Frontières –

    Three weeks on from the large-scale ground offensive by the Rapid Support Forces (RSF) on Zamzam camp, Sudan, in early April 2025, reports of intensified fighting in El-Fasher continue, and more displaced people are arriving in Tawila, North Darfur state. People have been arriving in Tawila in a vulnerable state; many are suffering from malnutrition, and others were injured during the attack on Zamzam camp. Médecins Sans Frontières’ (MSF’s) emergency and nutrition service at the hospital in Tawila has been overwhelmed.

    “They came with their machine guns. They attacked and killed people – including children. They burnt our house, with everything we had inside. They raped the women. They killed, they looted,” says Mariam*, who reached Tawila three days after the attack on Zamzam took place. “Even before the attack, people had died of thirst and of starvation because of the siege that had been imposed on Zamzam for the past year. Everything was so expensive and so unaffordable in the end.”

    Mariam* arrived with her mother, her sisters and their children- a household of 20 people. All of them now spend their days squeezed against each other under the makeshift shelter they built with a few branches and a piece of fabric.

    “Here, there is no food. A few people in Tawila shared a bit of millet flour with us, which we used to make porridge. This is how we have survived so far: begging,” she says. “We get the water from a tank, but they only let us fill one jerrycan per family, and we are 20 in ours. We only have one blanket for all of us.” 

    Since 12 April, when people first began reaching Tawila from Zamzam, the areas surrounding the town have been completely transformed, with tens of thousands of people now estimated to be living in makeshift shelters in fields that were totally uninhabited just a few weeks ago.

    “For four days now, we have been staying here as you see us, with nothing: no walls, no roof,” says Ibrahim*, who fled Zamzam on foot with 11 of his family members. He carried one of his children on his shoulders and another on his back for five days. It’s the fourth time in ten years he has been displaced in similar circumstances. He described how soldiers entered people’s homes, brought them outside and opened fire. Three of his brothers were killed like this. On his way to Tawila, he got looted and witnessed people being beaten so harshly that they could no longer move.

    “Under this tree, it is so crowded, we’re lacking water, or shelter… there is nothing to eat, everyone is hungry,” he says. “We’re getting some food from the community kitchens. Sometimes, we manage to get some rice when they distribute the meals, but if we don’t, we must wait until the next day to eat something. For water, we go to a borehole, but there are so many people, and we have to wait hours to be able to drink.” 

    A handful of organisations are present in Tawila, but the number of people in need of assistance far exceed the capacity to respond. MSF teams have set up two health posts at the main arrival sites to provide the newcomers with water and immediate nutrition and medical support. We are also referring critical patients to Tawila local hospital, where MSF has been working since October 2024.

    Tiphaine Salmon, MSF’s head nurse, was working in the Tawila hospital on 12 April, the day people began arriving with serious injuries.

    “The emergency room was overwhelmed,” she says. “Over the first few days, the number of patients in the hospital almost doubled. At one point, we had four patients in a bed because we did not have enough space.”

    “A lot of people had gunshot wounds and blast injuries – we’ve treated 779 people over the past three weeks, including 138 children. 187 of all the patients were severe cases,” says Salmon. “The youngest I saw was a seven-month-old baby with a bullet wound that went under his chin and into his shoulder. We also received patients as young as one day old suffering from dehydration. Many children arrived without their parents – and many parents were searching desperately for their children.”

    At the same time, MSF teams in the hospital witnessed an explosion of admissions in our intensive therapeutic feeding centre, which treats children under five-year-old suffering from severe acute malnutrition in addition of other comorbidities. In the week following the initial influx, admissions increased almost tenfold from an average of six or seven per week, to more than 60. They were mostly children from Zamzam, showing how desperate the nutrition situation was in the famine-stricken camp.

    To make the situation even worse, a suspected measles outbreak began in Tawila in March. In the hospital, MSF treated more than 900 suspected measles cases since early February, with more than 300 people in such a severe condition that they required hospitalisation. This led our teams to launch a large-scale vaccination campaign in the city on the first week of April, reaching 18,000 children under five. But one week after the massive influx of people from Zamzam began, our teams saw several suspected cases among children who had just arrived.

    Malnutrition and measles, in such sites with a highly dense population and poor hygiene conditions, can be an especially deadly combination for young children.

    MSF is continuing to scale-up our intervention in Tawila. On top of carrying out hundreds of medical consultations per day, we have also donated dry food to local community kitchens, enabling them to prepare and distribute more than 16,000 meals per day. We are providing 100,000 litres of clean water daily and we have additional plans to construct 300 latrines.

    People’s needs remain immense and far exceed our capacity to respond. Although other actors have also mobilised, and a first mass food distribution has taken place, the humanitarian response still needs to be urgently and rapidly scaled up. We urge UN agencies to substantially increase their presence on the ground so that they can coordinate a response of a magnitude that will meet the ever-growing needs.

    *Names changed.

    MIL OSI NGO

  • MIL-OSI NGOs: People arriving in Tawila from besieged Zamzam camp met with overwhelmed humanitarian response

    Source: Médecins Sans Frontières –

    Three weeks on from the large-scale ground offensive by the Rapid Support Forces (RSF) on Zamzam camp, Sudan, in early April 2025, reports of intensified fighting in El-Fasher continue, and more displaced people are arriving in Tawila, North Darfur state. People have been arriving in Tawila in a vulnerable state; many are suffering from malnutrition, and others were injured during the attack on Zamzam camp. Médecins Sans Frontières’ (MSF’s) emergency and nutrition service at the hospital in Tawila has been overwhelmed.

    “They came with their machineguns. They attacked and killed people – including children. They burnt our house, with everything we had inside. They raped the women. They killed, they looted,” says Mariam*, who reached Tawila three days after the attack on Zamzam took place. “Even before the attack, people had died of thirst and of starvation because of the siege that had been imposed on Zamzam for the past year. Everything was so expensive and so unaffordable in the end.”

    Mariam* arrived with her mother, her sisters and their children- a household of 20 people. All of them now spend their days squeezed against each other under the makeshift shelter they built with a few branches and a piece of fabric.

    “Here, there is no food. A few people in Tawila shared a bit of millet flour with us, which we used to make porridge. This is how we have survived so far: begging,” she says. “We get the water from a tank, but they only let us fill one jerrycan per family, and we are 20 in ours. We only have one blanket for all of us.” 

    Since 12 April, when people first began reaching Tawila from Zamzam, the areas surrounding the town have been completely transformed, with tens of thousands of people now estimated to be living in makeshift shelters in fields that were totally uninhabited just a few weeks ago.

    “For four days now, we have been staying here as you see us, with nothing: no walls, no roof,” says Ibrahim*, who fled Zamzam on foot with 11 of his family members. He carried one of his children on his shoulders and another on his back for five days. It’s the fourth time in ten years he has been displaced in similar circumstances. He described how soldiers entered people’s homes, brought them outside and opened fire. Three of his brothers were killed like this. On his way to Tawila, he got looted and witnessed people being beaten so harshly that they could no longer move.

    “Under this tree, it is so crowded, we’re lacking water, or shelter… there is nothing to eat, everyone is hungry,” he says. “We’re getting some food from the community kitchens. Sometimes, we manage to get some rice when they distribute the meals, but if we don’t, we must wait until the next day to eat something. For water, we go to a borehole, but there are so many people, and we have to wait hours to be able to drink.” 

    A handful of organisations are present in Tawila, but the number of people in need of assistance far exceed the capacity to respond. MSF teams have set up two health posts at the main arrival sites to provide the newcomers with water and immediate nutrition and medical support. We are also referring critical patients to Tawila local hospital, where MSF has been working since October 2024.

    Tiphaine Salmon, MSF’s head nurse, was working in the Tawila hospital on 12 April, the day people began arriving with serious injuries.

    “The emergency room was overwhelmed,” she says. “Over the first few days, the number of patients in the hospital almost doubled. At one point, we had four patients in a bed because we did not have enough space.”

    “A lot of people had gunshot wounds and blast injuries – we’ve treated 779 people over the past three weeks, including 138 children. 187 of all the patients were severe cases,” says Salmon. “The youngest I saw was a seven-month-old baby with a bullet wound that went under his chin and into his shoulder. We also received patients as young as one day old suffering from dehydration. Many children arrived without their parents – and many parents were searching desperately for their children.”

    At the same time, MSF teams in the hospital witnessed an explosion of admissions in our intensive therapeutic feeding centre, which treats children under five-year-old suffering from severe acute malnutrition in addition of other comorbidities. In the week following the initial influx, admissions increased almost tenfold from an average of six or seven per week, to more than 60. They were mostly children from Zamzam, showing how desperate the nutrition situation was in the famine-stricken camp.

    To make the situation even worse, a suspected measles outbreak began in Tawila in March. In the hospital, MSF treated more than 900 suspected measles cases since early February, with more than 300 people in such a severe condition that they required hospitalisation. This led our teams to launch a large-scale vaccination campaign in the city on the first week of April, reaching 18,000 children under five. But one week after the massive influx of people from Zamzam began, our teams saw several suspected cases among children who had just arrived.

    Malnutrition and measles, in such sites with a highly dense population and poor hygiene conditions, can be an especially deadly combination for young children.

    MSF is continuing to scale-up our intervention in Tawila. On top of carrying out hundreds of medical consultations per day, our organisation has also donated dry food to local community kitchens, enabling them to prepare and distribute more than 16,000 meals per day. We are providing 100,000 litres of clean water daily and we have additional plans to construct 300 latrines.

    People’s needs remain immense and far exceed our capacity to respond. Although other actors have also mobilised, and a first mass food distribution has taken place, the humanitarian response still needs to be urgently and rapidly scaled up. We urge UN agencies to substantially increase their presence on the ground so that they can coordinate a response of a magnitude that will meet the ever-growing needs.

    MIL OSI NGO

  • MIL-OSI Canada: One Case of Measles Found in HRM

    Source: Government of Canada regional news

    Nova Scotia has its first case of measles in 2025, found in Halifax Regional Municipality.

    The case involves a Nova Scotian who travelled outside Canada. The person had received one dose of vaccine, but people generally need two to be fully vaccinated.

    There are measles outbreaks around the globe, including in other provinces and the United States. The last case in Nova Scotia was in 2023 and also travel-related.

    Measles is a highly contagious disease that can lead to serious consequences, including death. It is spread when an infected person breathes, coughs or sneezes. Measles is rare in Nova Scotia because it is preventable by getting vaccinated and is part of routine childhood immunizations. The vaccine, which is free, is safe and very effective at providing lifelong protection.

    There is no treatment for measles.

    “Measles is not an illness to take lightly,” said Dr. Robert Strang, Nova Scotia’s Chief Medical Officer of Health. “It is highly contagious and lingers for hours in a location after an infected person leaves. I highly recommend people check their vaccination status and get vaccinated if needed. Measles vaccines are safe, effective and have been protecting us for decades.”

    People born 1970 to 1995 were offered one dose of measles vaccine as children, and if they have not had a second dose, they should get one now. Those born in 1996 or later were offered two doses of measles vaccine but should get fully vaccinated now if they missed one or both doses.

    Public Health also recommends infants six to 11 months of age receive a single dose of measles vaccine if they are travelling outside of Canada. People born in 1969 or earlier are generally considered immune but can consider receiving a single dose of measles vaccine if travelling outside of Canada.

    There is no risk in getting the vaccine for people who have received it previously.

    People can receive vaccinations from their routine vaccine provider, including family doctor, nurse practitioner, primary care pharmacist, public health office and special measles clinics.

    Measles has an incubation period of seven to 21 days after infection. Initial symptoms of measles include:

    • fever
    • cough
    • runny nose
    • red, watery eyes
    • small, white spots may appear inside the mouth and throat two to three days after symptoms begin.

    More severe cases of measles may result in pneumonia, ear infections, swelling of the brain, blindness and death.

    More information about measles and special measles clinics for immunization is available at: https://www.nshealth.ca/public-health/infectious-diseases/measles


    Quick Facts:

    • complications from measles can include respiratory failure, inflammation and swelling of the brain, blindness, deafness and brain injury
    • over the last month, more than 2,000 people have received the vaccine in Nova Scotia Health measles clinics

    Additional Resources:

    Health Canada information on measles: https://www.canada.ca/en/public-health/services/diseases/measles.html


    MIL OSI Canada News

  • MIL-OSI USA: FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities

    Source: US Department of Health and Human Services – 3

    For Immediate Release:
    May 06, 2025

    Today, the U.S. Food and Drug Administration announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for American consumers and patients. This change builds upon the agency’s Office of Inspection and Investigations Foreign Unannounced Inspection Pilot program in India and China and aims to ensure that foreign companies will receive the same level of regulatory oversight and scrutiny as domestic companies.  
    “For too long, foreign companies have enjoyed a double standard—given advanced notice before facility inspections, while American manufacturers are held to rigorous standards with no such warning. That ends today. This is a key step for the FDA as part of a broader strategy to get foreign inspections back on track,” said FDA Commissioner Martin A. Makary, M.D, M.P.H.  
    In addition, the FDA will evaluate the agency’s policies and practices for improvements to the foreign inspection program to ensure that the FDA is the gold standard for regulatory oversight. These changes will include clarifying policies for FDA investigators to refuse travel accommodations from regulated industry including lodging and transportation arrangements (taxi, limousine, and for-hire vehicle transit), to maintain the integrity of the oversight process.
    The FDA conducts approximately 12,000 domestic inspections and 3,000 foreign inspections each year in more than 90 countries. While U.S. manufacturers undergo frequent, unannounced inspections, foreign firms have often had weeks to prepare, undermining the integrity of the oversight process. Despite the advanced warning that foreign firms receive, the FDA still found serious deficiencies more than twice as often than during domestic inspections.  
    Only in specific programs and cases are the FDA’s domestic inspections pre-announced to assure that appropriate records and personnel will be available during the inspection. But regulated companies do not have the authority to negotiate the day or time of the inspection— nor should foreign companies have the capability to do so either. With this shift, the FDA is further ensuring that every product entering the U.S. is safe, legitimate, and honestly made. Unannounced inspections will also help expose bad actors—those who falsify records or conceal violations—before they can put American lives at risk. The FDA is authorized to take regulatory action against any firm that seeks to delay, deny, or limit an inspection, or refuses to permit entry for an unannounced drug or device inspection.
    “The FDA’s rigorous, science-based global inspections of manufacturing facilities ensure that the food and drug products that enter the U.S. marketplace, and the homes of American consumers, are safe, trusted, and accessible,” said FDA Assistant Commissioner for Inspections and Investigations Michael Rogers. “These inspections provide real-time evidence and insights that are essential for making fact-based regulatory decisions to protect public health.”
    The FDA’s global inspections generate real-time intelligence that strengthens enforcement and keeps American families safe. Every inspection goes through a classification assignment process to enable an appropriate regulatory response. Even inspections that yield a “No Action Indicated” provide important regulatory intelligence that strengthens the safety net for American consumers.   This expanded approach marks a new era in FDA enforcement—stronger, smarter, and unapologetically in support the public health and safety of Americans. For more information about FDA inspections, visit the Inspections Database Frequently Asked Questions and Inspections Yield Valuable Results, Regardless of Classification.
    ###

    Boilerplate

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.

    Inquiries

    Consumer:
    888-INFO-FDA

    Content current as of:
    05/06/2025

    Follow FDA

    MIL OSI USA News

  • MIL-OSI NGOs: Congolese refugees face humanitarian emergency in Burundi

    Source: Médecins Sans Frontières –

    Thousands of Congolese refugees who fled violence in the Democratic Republic of Congo (DRC) are now living in extremely precarious conditions in the designated Musenyi site in Burundi. Médecins Sans Frontières (MSF) has launched an emergency response to reduce the risk of measles and malaria, but more support is needed as people’s humanitarian needs remain largely unmet.

    Since the beginning of the year, thousands of people have fled fighting and insecurity in the provinces of North and South Kivu in the DRC. Crossing the Rusizi river into Burundi, they have hastily set up camp in schools, sheds, churches and stadiums in the province of Cibitoke on the border with South Kivu.

    In March, the Burundian authorities and the Office of the High Commissioner for Refugees (UNHCR) relocated the refugees to the Musenyi site, an official site inaugurated in 2024 in the south-east to provide basic facilities and services for up to 10,000 refugees.

    Megaphone in hand, an MSF community mobiliser walks around the Musenyi refugee site to encourage parents to vaccinate their children against measles. Burundi, April 2025.
    Dorine Niyungeko/MSF

    Unfortunately, the site’s capacity was quickly exceeded: according to UNHCR, by the end of April, some 18,000 refugees were living at the Musenyi site. Unsurprisingly, their living conditions quickly became unbearable and created health risks for adults and children alike.

    “I’ve been living in a shed since I arrived because there aren’t enough shelters for everyone,” says Nathalie*, a refugee who arrived in February. “Tarpaulins are given to large families to make shelters. But I live here, and we sleep in this shed, without mattresses, with toads, and moisture everywhere. We feel abandoned.”

    Built on poorly drained clay soil, the Musenyi site is particularly prone to flooding during the rainy season. Now, since the end of April, the rainy season has begun and, although drainage channels have been dug, water is stagnating in many parts of the site. People are trying to protect their shelters and the communal latrines as best they can to prevent the dirty water from spilling into the alleyways.

    “There is an urgent need to improve the living conditions on this site, as all the elements for serious health problems are present,” says Barbara Turchet, MSF’s emergency coordinator in Burundi. “Given the hygiene conditions, we have started to set up isolation units as a preventive measure in case of a cholera outbreak. And to reduce the risk of malaria, which is exacerbated by the amount of stagnant water everywhere, we have distributed more than 8,000 mosquito nets and are planning long-term mosquito spraying at the site.”

    Given the concentration of children at the site, MSF has also helped the health authorities organise a measles vaccination campaign, as several cases of this highly infectious but preventable disease have already been confirmed among the refugees.

    “We set up four vaccination points,” says Turchet. “We were able to vaccinate 8,500 children against measles and treat those who were infected. That’s something, but we have to do more to improve the refugees’ situation and protect their health.”

    Essential services overwhelmed as aid funding contracts

    A few organisations other than MSF are also present to offer healthcare to the refugees, but many people are unhappy with the insufficient access to care.

    “Here, refugees living with HIV have no access to treatment,” says Henri*, a refugee from South Kivu who was moved to Musenyi site from another in Burundi. “When we were in Rugombo, [also] in the province of Cibitoke, there was medical follow-up and treatment. But here, the health facilities don’t offer this kind of care.”

    In Musenyi, as in many other places today, humanitarian organisations are struggling to provide sufficient support because funding has decreased. Several humanitarian agencies are unable to provide sufficient medical follow-up for patients in the clinics they support. Food distributions are also clearly inadequate, further increasing the vulnerability of families. The UN estimates that US$76 million are required to meet the humanitarian needs of Congolese refugees in Burundi.

    “The gravity of the situation is real and calls for more attention and support,” warns Turchet. “At our level, we are doing our utmost and have extended our support to provide medical care for victims of sexual violence and psychosocial support for refugees suffering from mental health problems. But there are needs everywhere…”

    *Names have been changed for confidentiality

    MIL OSI NGO

  • MIL-OSI: Banzai Secures Expanded Agreement with RBC Capital Markets for OpenReel Enterprise License

    Source: GlobeNewswire (MIL-OSI)

    SEATTLE, May 06, 2025 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced it has expanded its agreement with RBC Capital Markets.

    As part of the expanded agreement, RBC Capital Markets’ Wealth Marketing Division will have an enterprise license for usage of OpenReel, Banzai’s leading digital video creation platform.

    “This agreement reinforces our strategy of expansion in the enterprise,” said Joe Davy, Founder and CEO of Banzai. “Having already been working with RBC Global Asset Management, this deal shows movement throughout the enterprise into the wealth marketing division, doubling our current engagement and validating our growth in the enterprise space. We are seeing solid traction in the financial sector, where the OpenReel Creator tool gives global financial firms the ability to offer standardized branded video with personalization at scale for their wealth managers, partners, and other stakeholders.”

    OpenReel empowers organizations to efficiently produce high-quality, branded video content at scale. Its platform enables users to remotely direct, record, edit, and collaborate on professional-grade video projects, significantly streamlining the production process and ensuring brand consistency. OpenReel serves a global enterprise client base, including industry leaders like Bristol Myers Squibb, Ingram Micro, DXC Technology, Insider Inc., and US Steel.

    About RBC Capital Markets

    The most significant corporations, institutional investors, asset managers, private equity firms, and governments around the globe recognize RBC Capital Markets as an innovative, trusted partner with an in-depth expertise in capital markets, banking, and finance. We are well-established in the largest, most mature capital markets across North America, Europe, and the Asia Pacific region, which collectively encompasses 80% of the global investment banking fee pool.

    RBC Capital Markets is part of a leading provider of financial services, Royal Bank of Canada (RBC). Founded in 1864, RBC is one of the largest banks in the world and the fifth largest in North America, as measured by market capitalization. With a strong capital base and consistent financial performance, RBC is among a small group of highly rated global banks. Learn more at rbccm.com.

    We are proud to support a broad range of community initiatives through donations, community investments and employee volunteer activities. See how at rbc.com/community-social-impact.

    About Banzai

    Banzai is a marketing technology company that provides AI-enabled marketing and sales solutions for businesses of all sizes. On a mission to help their customers grow, Banzai enables companies of all sizes to target, engage, and measure both new and existing customers more effectively. Customers who use Banzai’s product suite include Autodesk, Dell Technologies, New York Life, Thermo Fisher Scientific, Thinkific, and ActiveCampaign, among thousands of others. Learn more at www.banzai.io. For investors, please visit https://ir.banzai.io.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often use words such as “believe,” “may,” “will,” “estimate,” “target,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “propose,” “plan,” “project,” “forecast,” “predict,” “potential,” “seek,” “future,” “outlook,” and similar variations and expressions. Forward-looking statements are those that do not relate strictly to historical or current facts. Examples of forward-looking statements may include, among others, statements regarding Banzai International, Inc.’s (the “Company’s”): future financial, business and operating performance and goals; annualized recurring revenue and customer retention; ongoing, future or ability to maintain or improve its financial position, cash flows, and liquidity and its expected financial needs; potential financing and ability to obtain financing; acquisition strategy and proposed acquisitions and, if completed, their potential success and financial contributions; strategy and strategic goals, including being able to capitalize on opportunities; expectations relating to the Company’s industry, outlook and market trends; total addressable market and serviceable addressable market and related projections; plans, strategies and expectations for retaining existing or acquiring new customers, increasing revenue and executing growth initiatives; and product areas of focus and additional products that may be sold in the future. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity and development of the industry in which the Company operates may differ materially from those made in or suggested by the forward-looking statements. Therefore, investors should not rely on any of these forward-looking statements. Factors that may cause actual results to differ materially include changes in the markets in which the Company operates, customer demand, the financial markets, economic, business and regulatory and other factors, such as the Company’s ability to execute on its strategy. More detailed information about risk factors can be found in the Company’s Annual Report on Form 10-K and the Company’s Quarterly Reports on Form 10-Q under the heading “Risk Factors,” and in other reports filed by the Company, including reports on Form 8-K. The Company does not undertake any duty to update forward-looking statements after the date of this press release.

    Investor Relations
    Chris Tyson
    Executive Vice President
    MZ Group – MZ North America
    949-491-8235
    BNZI@mzgroup.us
    www.mzgroup.us

    Media
    Nancy Norton
    Chief Legal Officer, Banzai
    media@banzai.io

    The MIL Network

  • MIL-OSI United Kingdom: Year 8 pupils offered life saving HPV vaccine

    Source: City of Wolverhampton

    The HPV vaccination programme, offered to girls since 2008 and boys from 2019, has markedly reduced HPV infections and rates of cervical cancer.

    It also helps protect against genital warts and some cancers of the genital areas and anus, as well as some mouth and throat cancers.

    However, with over a quarter of eligible pupils missing out on this vital life saving protection each year, the UK Health Security Agency is urging parents to give consent so their children don’t miss out.

    Consent forms have been provided by secondary schools, but parents and guardians can also provide consent by visiting the Vaccination UK website.

    Councillor Jasbir Jaspal, the City of Wolverhampton Council’s Cabinet Member for Adults and Wellbeing, said: “We’re urging parents of children eligible for the HPV vaccine to give their consent as soon as possible, as it helps protect against a virus causing mouth and throat cancer, and nearly all cases of cervical cancer.

    “Hundreds of women die of cervical cancer in England each year but data suggests that 99.8% of cases of cervical cancer are preventable through HPV vaccination and cervical screening, so this vaccine is crucial in our drive to eliminate the disease.”

    Dr Sharif Ismail, Consultant Epidemiologist at UKHSA, added: “The HPV vaccine is one of the most successful in the world, given as just a single dose helping to prevent HPV related cancers from developing in both boys and girls.

    “Some parents may still think that HPV is just for girls to protect against cervical cancer, but since 2019 the vaccine is also offered to all boys in Year 8 – protecting both boys and girls from several cancers caused by the HPV virus.”

    MIL OSI United Kingdom

  • MIL-Evening Report: What’s the difference between osteoarthritis and rheumatoid arthritis?

    Source: The Conversation (Au and NZ) – By Giovanni E. Ferreira, NHMRC Emerging Leader Research Fellow, Institute of Musculoskeletal Health, University of Sydney

    Douglas Olivares/Shutterstock.

    Arthritis – an umbrella term for around 100 conditions that damage the joints – affects 4.1 million Australians. This is expected to rise by 31% to 5.4 million by 2040 and cost the Australian health-care system an estimated $12 billion each year.

    The two most common types, osteoarthritis and rheumatoid arthritis, can both cause joint pain, swelling and stiffness. Both are more common in women. Neither can be cured.

    But their causes, risk factors and treatments are different – here’s what you need to know.

    What is osteoarthritis?

    Osteoarthritis is the most common form of arthritis. It affects 2.1 million Australians, mostly older people. About a third of Australians aged 75 and older have the condition.

    It can affect any joint but is most common in the knees, hips, fingers, thumbs and big toes.

    The main symptom is pain, especially during movement. Other symptoms may include swelling, stiffness and changes to the shape of joints.

    The main risk factors are ageing and obesity, as well as previous injuries or surgery. For osteoarthritis in the hands, genetics also play a big role.

    Signs of osteoarthritis can appear on knee scans from around age 45 and become more common with age.

    However, this type of arthritis not simply the “wear and tear” of ageing. Osteoarthritis is a complex disease that affects the whole joint. This includes the cartilage (“shock-absorbing” connective tissue protecting your bones), bones, ligaments (connective tissue holding bones and body parts in place) and joint lining.

    Osteoarthritis can change the shape of joints such as knuckles.
    joel bubble ben/Shutterstock

    How is it diagnosed?

    Diagnosis is based on symptoms (such as pain and restricted movement) and a physical exam.

    The disease generally worsens over time and cannot be reversed. But the severity of damage does not always correlate with pain levels.

    For this reason, x-rays and MRI scans are usually unhelpful. Some people with early osteoarthritis experience severe pain, but the damage won’t show up on a scan. Others with advanced and visible osteoarthritis may have few symptoms or none at all.

    What about rheumatoid arthritis?

    Unlike osteoarthritis, rheumatoid arthritis is an autoimmune disease. This means the immune system attacks the joint lining, causing inflammation and damage.

    Common symptoms include pain, joint swelling and stiffness, especially in the morning.

    Rheumatoid arthritis is less common than osteoarthritis, affecting around 514,000 Australians. It mostly impacts the wrists and small joints in the hands and feet, though larger joints such as the elbows, shoulders, knees and ankles can also be involved.

    It can also affect other organs, including the skin, lungs, eyes, heart and blood vessels. Fortunately, disease outside the joint has become less common in recent years, likely due to better and earlier treatment.

    Rheumatoid arthritis often develops earlier than osteoarthritis but can occur at any age. Onset is most frequent in those aged 35–64. Smoking increases your risk.

    How is it diagnosed?

    As with osteoarthritis, your doctor will diagnose rheumatoid arthritis based on your symptoms and a physical exam.

    Some other tests can be useful. Blood tests may pick up specific antibodies that indicate rheumatoid arthritis, although you can still have the condition with negative results.

    X-rays may also reveal joint damage if the disease is advanced. If there is uncertainty, an ultrasound or MRI can help detect inflammation.


    The Conversation, CC BY-SA

    How is osteoarthritis treated?

    No treatment can stop osteoarthritis progressing. However many people manage their symptoms well with advice from their doctor and self-care. Exercise, weight management and pain medicines can help.

    Exercise has been shown to be safe for osteoarthritis of the knee, hip and hand. Many types of exercise are effective at reducing pain, so you can choose what suits you best.

    For knee osteoarthritis, managing weight through diet and/or exercise is strongly recommended. This may be because it reduces pressure on the joint or because losing weight can reduce inflammation. Anti-obesity medicines may also reduce pain.

    Exercise can help manage weight and is safe and effective at managing joint pain.
    gelog67/Shutterstock

    Topical and oral anti-inflammatories are usually recommended to manage pain. However, opioids (such as tramadol or oxycodone) are not, due to their risks and limited evidence they help.

    In some cases antidepressants such as duloxetine may also be considered as a treatment for pain though, again, evidence they help is limited.

    What about rheumatoid arthritis?

    Treatments for rheumatoid arthritis focus on preventing joint damage and reducing inflammation.

    It’s essential to get an early referral to a rheumatologist, so that treatment with medication – called “disease-modifying anti-rheumatic drugs” – can begin quickly.

    These medicines suppress the immune system to stop inflammation and prevent damage to the joint.

    With no cure, the overall goal is to achieve remission (where the disease is inactive) or get symptoms under control.

    Advances in treatment

    There is an increasing interest in prevention for both types of arthritis.

    A large international clinical trial is currently investigating whether a diet and exercise program can prevent knee osteoarthritis in those with higher risk – in this case, women who are overweight and obese.

    For those already affected, new medicines in early-stage clinical trials show promise in reducing pain and improving function.

    There is also hope for rheumatoid arthritis with Australian researchers developing a new immunotherapy. This treatment aims to reprogram the immune system, similar to a vaccine, to help people achieve long-term remission without lifelong treatment.

    Giovanni E. Ferreira receives funding from The National Health and Medical Research Council, HCF Research Foundation, and Ramsay Hospital Research Foundation.

    Rachelle Buchbinder receives research funding from The National Health and Medical Research Council, Medical Research Future Fund, the Australian government, HCF Foundation and Arthritis Australia.

    ref. What’s the difference between osteoarthritis and rheumatoid arthritis? – https://theconversation.com/whats-the-difference-between-osteoarthritis-and-rheumatoid-arthritis-249154

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI Europe: Written question – EMA’s role in COVID-19 vaccine approval procedures, inspections and good clinical practice checks – P-001695/2025

    Source: European Parliament

    Priority question for written answer  P-001695/2025
    to the Commission
    Rule 144
    Friedrich Pürner (NI)

    A recently published investigation by a German newspaper[1] has revealed that the European Medicines Agency (EMA) omitted or avoided crucial checks to test for side effects during the approval procedures for COVID-19 vaccines. Statutory good clinical practice checks by inspectors to review manufacturers’ clinical studies either did not take place or were limited in scope.

    • 1.Was the Commission aware of what happened? If so, when did it become aware and why did it not intervene?
    • 2.What inspection rules are in place for emergency use authorisation – particularly with regard to studies in non-EU countries – to make sure medicines are safe, the duty of care is upheld and patients are protected?
    • 3.Was the Commission informed by the EMA about occurrences of myocarditis (inflammation of the cardiac muscle) in Israel? If so, when (what date) and by whom (names of those involved), and how did the Commission handle this information on safety signals after mRNA vaccines were administered?

    Submitted: 28.4.2025

    • [1] https://www.welt.de/politik/plus256010158/Impfstoff-Kontrollen-Das-war-politisch-nicht-gewuenscht.html
    Last updated: 5 May 2025

    MIL OSI Europe News

  • MIL-OSI Europe: Written question – Liver damage as a side effect of COVID-19 vaccination – E-001675/2025

    Source: European Parliament

    Question for written answer  E-001675/2025
    to the Commission
    Rule 144
    Gerald Hauser (PfE)

    Scientific publications document cases of liver damage following vaccination against COVID-19, including immune-mediated hepatitis, acute liver cell injury and liver impairment in transplant patients. Here are a few examples:

    – Liver injury following SARS-CoV-2 vaccination: A multicenter case series[1]

    – Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome[2]

    – Histological and serological features of acute liver injury after SARS-CoV-2 vaccination[3]

    – Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines[4]

    – Severe de novo liver injury after Moderna vaccination – not always autoimmune hepatitis[5]

    Not only can liver damage be caused by mRNA vaccination, but the vaccines also have a wide range of other side effects.

    • 1.In hindsight, what does the Commission make of the scientific diligence shown in authorising the mRNA vaccines in view of the wide range of side effects they have?
    • 2.Are any investigations currently being carried out by the Commission or subordinate EU authorities into the safety of mRNA vaccines?
    • 3.Were potential hepatotoxicity, genotoxicity, cardiotoxic effects, immunotoxicity, neurotoxic effects and possible long-term effects on liver function and genetic integrity investigated when the mRNA vaccines were authorised?

    Submitted: 25.4.2025

    • [1] https://pubmed.ncbi.nlm.nih.gov/34339763/
    • [2] https://pubmed.ncbi.nlm.nih.gov/35567545/
    • [3] https://pubmed.ncbi.nlm.nih.gov/36440259/
    • [4] https://pubmed.ncbi.nlm.nih.gov/35817224/
    • [5] https://pubmed.ncbi.nlm.nih.gov/35439566/
    Last updated: 5 May 2025

    MIL OSI Europe News

  • MIL-OSI Security: Central Coast Woman Pleads Guilty to Misusing Doctors’ Credentials to Create Bogus Medical Documents for Immigration Applicants

    Source: Office of United States Attorneys

    LOS ANGELES – A San Luis Obispo County woman who operated a medical clinic pleaded guilty today to misusing physicians’ medical identities to create hundreds of fraudulent immigration documents to help immigrants obtain lawful status in the United States and for using a deceased doctor’s credentials to acquire and distributed controlled substances.

    Chantelle Lavergne Woods, 54, of Nipomo, pleaded guilty to one count of presentation of false immigration document or application and one count of possession with intent to distribute phendimetrazine. Woods is free on $10,000 bond.

    According to her plea agreement, Woods formerly operated and managed a clinic in Arroyo Grande that at times was known as “Medical Weight Loss and Immigration Services.” Beginning in February 2021, Woods knowingly misused the identities of three physicians to create hundreds of fraudulent documents pertaining to medical examinations of individuals seeking to register for a lawful permanent resident (LPR) card – commonly known as a “green card” – or otherwise adjust their immigration status.

    United States Citizenship and Immigration Services (USCIS) requires the submission of a medical examination and vaccination record that assess several physical and mental health factors to determine if an applicant is inadmissible to the United States on health-related grounds.

    Federal law requires licensed physicians to perform these examinations and then sign a form attesting, in part, that the physician performed the medical examination and truly and accurately completed the form based on the examination and the information provided by the applicant. Woods completed at least 328 such forms on which she falsely included the signature of medical doctors, thereby representing that the individual had been medically examined by a doctor, when in fact they had not.

    At times, there were no physicians present at the clinic, Woods acted without physician authorization, and the clinic did not provide legitimate medical services.

    Woods further admitted that – from February 2021 to June 2022 – she used the Drug Enforcement Administration (DEA) registration number of a deceased physician to order more than 150,000 tablets of controlled substances, including testosterone, codeine, alprazolam (sold under the brand name Xanax), diethylpropion (an appetite suppressant), and phentermine (weight-loss medicine).

    In July 2022, at the clinic, Woods knowingly and intentionally possessed with intent to distribute phendimetrazine – a weight-loss drug – as well as a loaded firearm.

    United States District Judge Fernando M. Olguin scheduled a July 31 sentencing hearing, at which time Woods will face a statutory maximum sentence of 10 years in federal prison for each count.

    The Drug Enforcement Administration’s Ventura Resident Office Tactical Diversion Squad and USCIS Fraud Detection and National Security investigated this matter.

    Assistant United States Attorney Jeremy K. Beecher of the Transnational Organized Crime Section is prosecuting this case.

    MIL Security OSI

  • MIL-OSI Australia: Pop-up clinics helping families stay well this winter

    Source: Northern Territory Police and Fire Services

    As part of ACT Government’s ‘One Government, One Voice’ program, we are transitioning this website across to our . You can access everything you need through this website while it’s happening.

    Released 06/05/2025

    The ACT Government is making it easier for parents and carers to protect our youngest community members with a series of free pop-up influenza vaccination clinics for children.

    Minister for Health Rachel Stephen-Smith said the clinics – for aged 6 months to under 5 years – are a simple and convenient way for busy parents to keep their little ones protected against serious illness.

    The clinics can be accessed via booking or walk-in and will be located across the ACT, in Belconnen, Gungahlin, Central Canberra, Tuggeranong and Weston Creek.

    This service is another part of our commitment to high quality, free healthcare for Canberrans. The clinics are a part of the biggest investment in healthcare in our Territory’s history.

    “Respiratory illnesses like influenza (flu) can be serious for young children, and an annual influenza vaccine is the best way to reduce the risk of your child getting sick with influenza and spreading it to others,” Minister Stephen-Smith said.

    “We know it can be challenging for families to find time while juggling work, childcare and daily responsibilities. That’s why we have set up these after-hours pop-up clinics to make it faster and more convenient for parents to get their child’s annual influenza vaccine.

    “The clinics are available to families with children aged from 6 months to under five, with locations across Canberra. Influenza vaccination for this age group is also available through ACT Early Childhood Immunisation Clinics and GPs, so there are a range of options for parents and carers to have their young children vaccinated.”

    “There are also other simple actions you can take to keep yourself and your family well this winter, including practising good hand hygiene, staying home if you’re unwell, keeping active and eating well.”

    ACT Chief Health Officer Dr Kerryn Coleman encouraged all Canberrans to look after their health and wellbeing this winter, starting with getting an influenza vaccination.

    “Respiratory viruses are more than just a cold and they can be far more serious than you think,” Dr Coleman said.

    “For best protection against influenza, it is recommended for everyone aged 6 months and over to be vaccinated every year.

    “Vaccinations are a safe and easy way to protect both yourself and the people in your community who are at risk and now is the perfect time to schedule an appointment to visit our pop-up clinics”.

    For many people, the influenza vaccine is free under the National Immunisation Program, although providers may charge a fee to administer the vaccine. This includes:

    • children aged six months to under five years
    • people aged 65 years and older
    • Aboriginal and Torres Strait Islander people aged six months and older
    • pregnant people
    • people aged six months or older with underlying medical conditions

    Influenza and COVID-19 vaccines are widely available from GPs and a range of pharmacies around Canberra as well as at selected public health facilities for some eligible people.

    Walk-ins at the clinics are welcome but a booking is recommended, which can be made through myDHR or by calling: 02 5124 9977.

    For more information on the pop-up influenza vaccination clinics visit www.act.gov.au and search ’pop up clinic’.

    – Statement ends –

    Rachel Stephen-Smith, MLA | Media Releases

    «ACT Government Media Releases | «Minister Media Releases

    MIL OSI News

  • MIL-OSI Africa: World Health Organization (WHO) Ghana Welcomes New Country Representative, Dr Fiona Braka

    Source: Africa Press Organisation – English (2) – Report:

    Download logo

    The World Health Organization (WHO) Ghana has welcomed Dr Fiona Braka as its new Country Representative, following official endorsement by the Government of Ghana.

    A seasoned public health expert from Uganda, Dr Braka brings to her new role over two decades of extensive experience in disease prevention and control, public health emergency management, and strategic leadership. She will lead WHO Ghana’s technical and operational work, collaborating with the Ministry of Health, key stakeholders and partners to strengthen health systems, improve health outcomes, and accelerate progress towards Universal Health Coverage and the health-related Sustainable Development Goals (SDGs).

    Before her appointment to Ghana, Dr Braka held several senior positions within WHO across Nigeria, Ethiopia, and Uganda. In these roles, she spearheaded initiatives to advance primary health care and public health security, while leading diverse teams in complex settings. Most recently, she served as Coordinator of Emergency Response Operations at WHO’s Regional Office for Africa in Brazzaville, Congo. In this capacity, she directed WHO’s response to major disease outbreaks and humanitarian crises across 47 countries and oversaw efforts to bolster national capacities for health emergency preparedness and response.

    Dr Braka played a pivotal role in the eradication of wild poliovirus in Nigeria, contributing to the African region’s certification as wild polio-free in 2020. As an immunization team lead in various countries, she supported the expansion of national vaccination programmes, helping to bring essential health services closer to underserved communities.

    As a dedicated contributor to global public health knowledge, Dr Braka has authored numerous publications in peer-reviewed journals. She holds a Medical Degree from Makerere University in Kampala, Uganda, and a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health in the United States of America.

    Her appointment marks a new chapter in WHO Ghana’s continued support to the country’s health sector.

    Distributed by APO Group on behalf of World Health Organization (WHO), Ghana.

    MIL OSI Africa

  • MIL-OSI: Virtune announces change of Index Provider

    Source: GlobeNewswire (MIL-OSI)

    Stockholm, 5 May 2025 – Virtune announces that as of May 12, 2025, the index provider for Virtune’s existing index ETPs will change to MarketVector IndexesTM (“MarketVector”). In addition, reference prices from MarketVector will be used for Virtune’s other ETPs.

    Notice of changed service provider within Virtune’s ETP program
    Virtune announces a change of index administrator, index calculation agent, and reference price provider to MarketVector for all of Virtune’s ETPs, which will be reflected in the updated final terms, available as of May 12, 2025.

    Please note that this change does not affect investors or the trading of Virtune’s ETPs and no action is required from investors.

    Change:
    New index administrator, index calculation agent and reference price provider: MarketVector Indexes GmbH
    Address: Voltastrasse 1, 60486 Frankfurt am Main, Germany

    Index change as of May 12, 2025, with MarketVector as new index administrator and index calculation agent:

    Virtune Crypto Top 10 Index ETP SEK (ISIN: SE0020052207): Change to Virtune Crypto Top 10 Index produced by MarketVector

    Virtune Crypto Top 10 Index ETP EUR (ISIN: SE0020052215): Change to Virtune Crypto Top 10 Index produced by MarketVector

    Virtune Crypto Altcoin Index ETP (ISIN: SE0023260716): Change to Virtune Crypto Altcoin Index produced by MarketVector

    The methodology for the above indexes and their respective components will remain essentially unchanged from the previous indexes and therefore have no impact on investors in these ETPs. Virtune will remain the index sponsor for the above indexes.

    Change of reference prices as of May 12, 2025, with MarketVector as new reference price provider:

    The following ETPs will use reference prices from MarketVector to calculate the daily Net Asset Value. This change has no impact on investors in these ETPs:

    ● Virtune Bitcoin ETP (ISIN: SE0020845709)
    ● Virtune Staked Ethereum ETP (ISIN: SE0020541639)
    ● Virtune Staked Solana (ISIN: SE0021309754)
    ● Virtune Staked Polkadot ETP (ISIN: SE0021148129)
    ● Virtune XRP ETP (ISIN: SE0021486156)
    ● Virtune Avalanche ETP (ISIN: SE0022050092)
    ● Virtune Chainlink ETP (ISIN: SE0021149259)
    ● Virtune Arbitrum ETP (ISIN: SE0021310133)
    ● Virtune Staked Polygon ETP (ISIN: SE0021630217)
    ● Virtune Staked Cardano ETP (ISIN: SE0021630449)
    ● Virtune Litecoin ETP (ISIN: SE0023951082)

    Press contact
    Christopher Kock, VD Virtune AB (Publ)
    Christopher@virtune.com
    +46 70 073 45 64

    About Virtune
    Virtune with its headquarters in Stockholm is a regulated Swedish digital asset manager and issuer of crypto exchange traded products on regulated European exchanges. With regulatory compliance, strategic collaborations with industry leaders and our proficient team, we empower investors on a global level to access innovative and sophisticated investment products that are aligned with the evolving landscape of the global crypto market.

    About MarketVector
    MarketVector IndexesTM (“MarketVector”) is a regulated benchmark administrator in Europe, registered in Germany and approved by the Federal Financial Supervisory
    Authority (BaFin). MarketVector maintains indexes under the names MarketVectorTM, MVIS®️ and BlueStar®️. With a mission to drive innovation in indexing globally, MarketVector is especially known for its broad range of thematic indexes, long-standing expertise in real asset-linked equity indexes, and its pioneering family of digital asset indexes. MarketVector proudly partners with more than 25 issuers of exchange-traded products (ETPs) and index fund managers across global markets, with approximately USD 50 billion in assets under management.

      
    Crypto investments are associated with high risk. Virtune does not provide investment advice. Investments are made at your own risk. Securities may increase or decrease in value, and there is no guarantee that you will recover your invested capital. Please read the prospectus, KID, terms at www.virtune.com.

    Attachment

    The MIL Network

  • MIL-OSI Canada: Don’t get measles. Get immunized.

    [. Alberta’s government is taking the current measles outbreaks seriously and is actively working to improve vaccination access and share information Albertans need to protect themselves.

    As cases increase, additional immunization appointments are being added daily to improve access to vaccines with an expansion of immunization clinic access across the central and south zones starting May 5. Clinics in the central zone will now have walk-in availability, including some with evening measles-specific clinics and additional Saturday availability. In the south zone, both evening and weekend appointments are being added.

    Alberta Health Services (AHS) has planned for and is ready to ramp up additional measles clinics across the province including extending hours at existing measles-specific clinics and opening additional clinic space, based on demand.

    Alberta’s government and AHS have also introduced a new early dose of measles-containing vaccines, now available for infants six to 11 months of age in the north, central, and south zones of the province. This is on top of the routine immunization schedule, which is two doses of measles-containing vaccine at 12 and 18 months of age.

    “Getting immunized against measles is the single most important thing you can do to protect yourself, your loved ones and your community. By expanding access to vaccines and reaching more Albertans with this advertising campaign, we hope more Albertans will protect themselves.”

    Adriana LaGrange, Minister of Health

    Public health officials are collaborating with AHS to manage the outbreak response. They are also working with local leadership in areas with the highest case numbers to support affected communities and increase vaccination efforts. Most cases remain traceable, and officials continue to monitor the situation closely.

    “We are looking at one of the largest outbreaks in nearly 40 years. When fewer people are protected, measles spreads—and the risks go up. Immunization is the best way to protect yourself and loved ones from measles. Get immunized against measles now and help prevent the spread. Help protect your communities.”

    Dr. Sunil Sookram, interim Chief Medical Officer of Health

    Starting Monday, May 5, HealthLink 811 is introducing a dedicated measles hotline. Albertans seeking information about measles can fast track their call through HealthLink by calling 1-844-944-3434. The measles hotline will speed up access to a professional who will:

    • Assist with accessing your immunization records or general information
    • Provide advice for those experiencing measles symptoms and are feeling unwell.
    • Assist with booking measles immunization appointments or locating a public health clinic offering immunization in your area.

    “Primary Care Alberta encourages all Albertans to check their vaccination records, and those of their children, to ensure that they are protected from the highly contagious measles virus. Our dedicated team is ready to help you confirm your vaccination status, or to assist you and your family if you suspect that you’ve been exposed to measles.”

    Kim Simmonds, CEO, Primary Care Alberta

    Alberta’s government is committed to providing the information needed to protect Albertans, with a dedicated measles webpage on alberta.ca. Albertans can visit the page, updated every weekday, for information related to the disease, including local exposure notifications issued by AHS to warn people of known exposure locations.

    Expanded advertising campaign launching next week

    Since late March, Alberta’s government has been running a social media campaign encouraging Albertans to check their immunization records to ensure they are protected against measles.

    To further raise awareness, an expanded provincewide Don’t get measles. Get Immunized awareness campaign is launching in mid-May across radio, print, digital, and social media. A toolkit is also being developed to share with daycare providers to further ensure parents have the information they need to protect their children.

    This campaign will also be translated into over 14 languages to help reach Albertans whose first language is not English. The additional languages in online ads will be French, Chinese, Punjabi, Spanish, Ukrainian, Urdu, and Tagalog. The additional languages in radio will be Arabic, French, Hindi, Korean, Farsi, Chinese (traditional and simplified), Somali, Spanish, Tagalog, Ukrainian, Urdu, and Vietnamese.

    Quick facts

    • Currently, appointments in the central zone are available within one day, while in the south zone appointments are available usually within one to two days.
    • Following increased efforts to educate Albertans on measles and the importance of immunization, there has been a significant rise in immunizations across the province. Since March 16, there has been a 67% increase in comparison to last year.
    • Data on measles, including total confirmed cases, is updated Monday to Friday on the government website.
    • Weekly updates on immunization rates are done every Thursday.
    • Albertans uncertain of their immunization history, or their child’s immunization history, can text “vaccine record” to 88111, call Health Link at 811 or their local public health office.
    • Albertans can also text “measles” to 88111 to get measles health information texted to their mobile device.
    • Symptoms of measles include:
      • fever of 38.3° C or higher
      • cough, runny nose and/or red eyes
      • a red, blotchy rash appears three to seven days after fever starts. It typically beginning behind the ears and on the face and spreads down the body and to the arms and legs

    Related information

    • MyHealth Alberta
    • Measles – Alberta.ca
    • Measles Exposures in Alberta – AHS

    Related news

    • Update on measles situations in Alberta (April 11, 2025)
    • Stay informed about measles in Alberta (March 14, 2025)

    Multimedia

    • Watch the news conference

    MIL OSI Canada News

  • MIL-OSI: MARA Announces Bitcoin Production and Mining Operation Updates for April 2025

    Source: GlobeNewswire (MIL-OSI)

    Energized Hash Rate Grew 5.5% to 57.3 EH/s
    Increased BTC Holdings* to 48,237 BTC

    Fort Lauderdale, FL, May 05, 2025 (GLOBE NEWSWIRE) — MARA Holdings, Inc. (NASDAQ: MARA) (“MARA” or the “Company”), a vertically integrated digital energy and infrastructure company that leverages high-intensity compute, such as bitcoin (“bitcoin” or “BTC”) mining, to monetize excess energy and optimize power management, today published unaudited bitcoin production updates for April 2025.

    Management Commentary

    “In April, our production saw a 15% month-over-month decrease in blocks won, as global hashrate had its second largest monthly gain on record and mining difficulty grew 8% from March,” said Fred Thiel, MARA’s chairman and CEO. “Despite these headwinds, our energized hashrate grew 5.5% over the prior month. We completed a 50-megawatt (“MW”) expansion at our fully owned data center in Ohio, bringing total operational capacity to 100 MW, with the site designed to scale up to 200 MW. Additionally, we installed over 12,000 S21 Pro miners at the location.

    “Last month, we fully energized our 25 MW gas-to-power operations across wellheads in North Dakota and Texas. These sites currently provide us with our lowest cost per BTC mined while monetizing excess gas and mitigating methane emissions for the producers.

    “We remain laser-focused on transforming MARA into a vertically integrated digital energy and infrastructure company. We believe this model gives us tighter operational control, improves cost-efficiency, and makes us more resilient to shifts in the broader economy.”

    Operational Highlights and Updates

    Figure 1: Operational Highlights

    Prior Month Comparison   Prior Month Comparison  
    Metric   4/30/2025     3/31/2025     % Δ  
    Number of Blocks Won 1     205       242       (15 )%
    BTC Produced     705       829       (15 )%
    Average BTC Produced per Day     23.5       26.8       (12 )%
    Share of available miner rewards 2     5.1 %     5.8 %     NM  
    Transaction Fees as % of Total 1     1.3 %     1.3 %     NM  
    Energized Hashrate (EH/s) 1     57.3       54.3       5.5 %
    1. These metrics are MARAPool only and do not include blocks won from joint ventures.
    2. Defined as the total amount of block rewards including transaction fees that MARA earned during the period divided by the total amount of block rewards and transaction fees awarded by the Bitcoin network during the period.

    NM – Not Meaningful

    As of April 30, 2025, the Company held a total of 48,237 BTC*. MARA opted not to sell any BTC in April.

    *Includes loaned and collateralized bitcoin

    Investor Notice

    Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks, uncertainties and forward-looking statements described under the heading “Risk Factors” in our most recent annual report on Form 10-K and any other periodic reports that we may file with the U.S. Securities and Exchange Commission (the “SEC”). If any of these risks were to occur, our business, financial condition or results of operations would likely suffer. In that event, the value of our securities could decline, and you could lose part or all of your investment. The risks and uncertainties we describe are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. In addition, our past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results in the future. See “Forward-Looking Statements” below.

    The operational highlights and updates presented in this press release pertain solely to our BTC mining operations. Detailed information regarding our other operations can be found in our periodic reports filed with the SEC.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the federal securities laws. All statements, other than statements of historical fact, included in this press release are forward-looking statements. The words “may,” “will,” “could,” “anticipate,” “expect,” “intend,” “believe,” “continue,” “target” and similar expressions or variations or negatives of these words are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Such forward-looking statements include, among other things, statements related to scaling our data center in Ohio, mitigating methane emissions at our gas-to-power operations in North Dakota and Texas and expected benefits of transforming from an asset-light model into a vertically integrated digital energy and infrastructure company. Such forward-looking statements are based on management’s current expectations about future events as of the date hereof and involve many risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in our forward-looking statements. Subsequent events and developments, including actual results or changes in our assumptions, may cause our views to change. We do not undertake to update our forward-looking statements except to the extent required by applicable law. Readers are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements included herein are expressly qualified in their entirety by these cautionary statements. Our actual results and outcomes could differ materially from those included in these forward-looking statements as a result of various factors, including, but not limited to, the factors set forth under the heading “Risk Factors” in our most recent annual report on Form 10-K, and any other periodic reports that we may file with the SEC.

    About MARA

    MARA (NASDAQ: MARA) is a vertically integrated digital energy and infrastructure company that leverages high-intensity compute, such as bitcoin mining, to monetize excess energy and optimize power management. We are focused on two key priorities: strategically growing by shifting our model toward low-cost energy with more efficient capital deployment and bringing to market a full suite of solutions for data centers and edge inference – including energy management, load balancing and advanced cooling.

    For more information, visit www.mara.com, or follow us on:

    Twitter: @MARAHoldings
    LinkedIn: www.linkedin.com/company/maraholdings
    Facebook: www.facebook.com/MARAHoldings
    Instagram: @maraholdingsinc

    MARA Company Contact:
    Telephone: 800-804-1690
    Email: ir@mara.com

    MARA Media Contact:
    Email: marathon@wachsman.com

    The MIL Network

  • MIL-OSI Europe: Written question – Violation of media freedom and pluralism in Tusk’s ‘militant democracy’ and EU values – E-001622/2025

    Source: European Parliament

    Question for written answer  E-001622/2025
    to the Commission
    Rule 144
    Mariusz Kamiński (ECR)

    ‘Media freedom and pluralism are a vital part of democracy and of the fundamental rights of EU citizens. True democracy is not possible without a free media scrutinising those in power. The media is a key pillar in the checks and balances that underpin democratic rule. That’s why the descent into authoritarian rule often starts with independent media being targeted. Over the last few decades, a number of states across the globe have taken this path, using coercion and often violence to persecute media outlets and individual journalists’[1] – quoted from the European Council website. This quote perfectly reflects the situation in Poland under the government of Donald Tusk.

    In light of the above:

    • 1.Does the Commission’s silence regarding the unlawful, forceful takeover of public service media using secret service methods, such as switching off the television signal[2], and the systemic destruction of opposition media through attempts to withdraw concessions[3], pressure advertisers[4], refuse admission to press conferences (including during life-threatening emergencies, such as flooding[5]) and the use of aggression and violence against journalists[6] not constitute an authorisation to destroy democracy in a Member State?
    • 2.Does the Commission consider that the system described by Donald Tusk as ‘militant democracy’, which includes the drastic examples of the destruction of media freedom and pluralism described above, to be in line with the values of the Union which the Commission is so eager to invoke?
    • 3.Is the Commission aware that Civic Platform is violating the law, including electoral rules, by discriminating against candidates and using public television and its resources to organise electoral agitation, as happened on 11 April in Końskie[7]?

    Submitted: 23.4.2025

    • [1] https://www.consilium.europa.eu/en/policies/media-freedom-eu/
    • [2] https://www.pap.pl/aktualnosci/wylaczono-nadawanie-kanalu-tvp-info-oraz-portalu-tvp-info-muller-nielegalne
    • [3] https://sdp.pl/zamach-na-wolnosc-slowa-cmwp-sdp-w-obronie-koncesji-naziemnej-dla-telewizji-republika-i-w-polsce24/
    • [4] https://www.press.pl/tresc/80495,prawicowi-dziennikarze-protestuja-przeciw-zastraszaniu-reklamodawcow-telewizji-republika_-podpisal-sie-tez-tomasz-sakiewicz
    • [5] https://www.press.pl/tresc/83971,prokuratura-wszczela-dochodzenie-ws_-niewpuszczania-dziennikarzy-republiki-na-konferencje-premiera https://biznesalert.pl/krrit-zlozyla-zawiadomienie-do-prokuratury-chodzi-o-informowanie-mediow-podczas-powodzi/
    • [6] https://sdp.pl/sdp-zlozy-do-prokuratury-ws-poturbowania-dziennikarza-tv-republika-podczas-wiecu-wyborczego-rafala-trzaskowskiego/
    • [7] https://wpolityce.pl/media/726640-szef-krrit-pisze-do-pkw-ws-udzialu-tvp-w-debacie-w-konskich
    Last updated: 5 May 2025

    MIL OSI Europe News